<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Crossfire by Rivet Software version 4.3.94.0 http://www.rivetsoftware.com-->
<!--Based on XBRL 2.1-->
<!--Created on: 12/20/2011 1:42:12 PM-->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:arwr="http://www.arrowheadresearch.com/20110930" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2011-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2011-01-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:schemaRef xlink:type="simple" xlink:href="arwr-20110930.xsd" />
  <!--Context Section-->
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTwoDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ExercisedAtTwoDollarPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTwoDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ExercisedAtTwoDollarPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTwoDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ExercisedAtTwoDollarPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTwoDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ExercisedAtTwoDollarPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ExercisedAtTenDollarPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ExercisedAtTenDollarPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ExercisedAtTenDollarPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ExercisedAtTenDollarPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTwoDollarPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ExercisedAtTwoDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTenDollarPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ExercisedAtTenDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2010_To_9_30_2011_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThreeDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2010_To_9_30_2011_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThreeDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2010_To_9_30_2011_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThreeDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2010_To_9_30_2011_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThreeDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2010_To_9_30_2011_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuanceOfCommonStockForSubscriptionMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuanceOfCommonStockForSubscriptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2010_To_9_30_2011_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuanceOfCommonStockForSubscriptionMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuanceOfCommonStockForSubscriptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2010_To_9_30_2011_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuanceOfCommonStockForSubscriptionMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuanceOfCommonStockForSubscriptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2010_To_9_30_2011_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuanceOfCommonStockForSubscriptionMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuanceOfCommonStockForSubscriptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2010_To_9_30_2011_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThreeDollarsAndEightyCentsPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThreeDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2010_To_9_30_2011_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuanceOfCommonStockForSubscriptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuanceOfCommonStockForSubscriptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedToCalandoStockholdersInExchangeForCalandoSSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedToCalandoStockholdersInExchangeForCalandoSSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedToCalandoStockholdersInExchangeForCalandoSSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedToCalandoStockholdersInExchangeForCalandoSSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirteenDollarsAndTwelveCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThirteenDollarsAndTwelveCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirteenDollarsAndTwelveCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThirteenDollarsAndTwelveCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirteenDollarsAndTwelveCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThirteenDollarsAndTwelveCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirteenDollarsAndTwelveCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThirteenDollarsAndTwelveCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtSixDollarsAndThirtyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtSixDollarsAndThirtyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtSixDollarsAndThirtyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtSixDollarsAndThirtyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtSixDollarsAndThirtyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtSixDollarsAndThirtyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtSixDollarsAndThirtyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtSixDollarsAndThirtyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToCalandoStockholdersInExchangeForCalandoSSharesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedToCalandoStockholdersInExchangeForCalandoSSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirteenDollarsAndTwelveCentsPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThirteenDollarsAndTwelveCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtSixDollarsAndThirtyCentsPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtSixDollarsAndThirtyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThreeDollarsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThreeDollarsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThreeDollarsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThreeDollarsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThreeDollarsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThreeDollarsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThreeDollarsPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThreeDollarsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThreeDollarsPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThreeDollarsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtApproximatelyEighteenDollarPerShareNetMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtApproximatelyEighteenDollarPerShareNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtApproximatelyEighteenDollarPerShareNetMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtApproximatelyEighteenDollarPerShareNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtApproximatelyEighteenDollarPerShareNetMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtApproximatelyEighteenDollarPerShareNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtApproximatelyEighteenDollarPerShareNetMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtApproximatelyEighteenDollarPerShareNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtApproximatelyEighteenDollarPerShareNetMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtApproximatelyEighteenDollarPerShareNetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirtyFiveDollarsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThirtyFiveDollarsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirtyFiveDollarsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThirtyFiveDollarsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirtyFiveDollarsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThirtyFiveDollarsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirtyFiveDollarsPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThirtyFiveDollarsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFortyEightDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFortyEightDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFortyEightDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFortyEightDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFortyEightDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFortyEightDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFortyEightDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFortyEightDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiftyNineDollarsAndTenCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFiftyNineDollarsAndTenCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiftyNineDollarsAndTenCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFiftyNineDollarsAndTenCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiftyNineDollarsAndTenCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFiftyNineDollarsAndTenCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiftyNineDollarsAndTenCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFiftyNineDollarsAndTenCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirtyFiveDollarsPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThirtyFiveDollarsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFortyEightDollarsAndEightyCentsPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFortyEightDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiftyNineDollarsAndTenCentsPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFiftyNineDollarsAndTenCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ExercisedAtTenDollarPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ExercisedAtTenDollarPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ExercisedAtTenDollarPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ExercisedAtTenDollarPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtFifteenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ExercisedAtFifteenDollarPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtFifteenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ExercisedAtFifteenDollarPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtFifteenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ExercisedAtFifteenDollarPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtFifteenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ExercisedAtFifteenDollarPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTenDollarPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ExercisedAtTenDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtFifteenDollarPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ExercisedAtFifteenDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForMarketableSecuritiesAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForMarketableSecuritiesAtTenDollarPerUnitMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForMarketableSecuritiesAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForMarketableSecuritiesAtTenDollarPerUnitMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForMarketableSecuritiesAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForMarketableSecuritiesAtTenDollarPerUnitMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForMarketableSecuritiesAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForMarketableSecuritiesAtTenDollarPerUnitMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForCashAtTenDollarPerUnitMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForCashAtTenDollarPerUnitMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForCashAtTenDollarPerUnitMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForCashAtTenDollarPerUnitMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtFifteenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForCashAtFifteenDollarPerUnitMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtFifteenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForCashAtFifteenDollarPerUnitMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtFifteenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForCashAtFifteenDollarPerUnitMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtFifteenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForCashAtFifteenDollarPerUnitMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForMarketableSecuritiesAtTenDollarPerUnitMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForMarketableSecuritiesAtTenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtTenDollarPerUnitMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForCashAtTenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtFifteenDollarPerUnitMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForCashAtFifteenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtZeroPointZeroOneDollarsPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForCashAtZeroPointZeroOneDollarsPerUnitMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtZeroPointZeroOneDollarsPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForCashAtZeroPointZeroOneDollarsPerUnitMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtZeroPointZeroOneDollarsPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForCashAtZeroPointZeroOneDollarsPerUnitMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtZeroPointZeroOneDollarsPerUnitMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForCashAtZeroPointZeroOneDollarsPerUnitMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForCashAtTenDollarPerUnitMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForCashAtTenDollarPerUnitMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForCashAtTenDollarPerUnitMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForCashAtTenDollarPerUnitMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtZeroPointZeroOneDollarsPerUnitMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForCashAtZeroPointZeroOneDollarsPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtTenDollarPerUnitMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForCashAtTenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTwoDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ExercisedAtTwoDollarPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ExercisedAtTenDollarPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2010_To_9_30_2011_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThreeDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2010_To_9_30_2011_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuanceOfCommonStockForSubscriptionMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuanceOfCommonStockForSubscriptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedToCalandoStockholdersInExchangeForCalandoSSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirteenDollarsAndTwelveCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThirteenDollarsAndTwelveCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtSixDollarsAndThirtyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtSixDollarsAndThirtyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThreeDollarsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThreeDollarsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtApproximatelyEighteenDollarPerShareNetMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtApproximatelyEighteenDollarPerShareNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirtyFiveDollarsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThirtyFiveDollarsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFortyEightDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFortyEightDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiftyNineDollarsAndTenCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFiftyNineDollarsAndTenCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ExercisedAtTenDollarPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtFifteenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ExercisedAtFifteenDollarPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForMarketableSecuritiesAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForMarketableSecuritiesAtTenDollarPerUnitMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForCashAtTenDollarPerUnitMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtFifteenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForCashAtFifteenDollarPerUnitMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtZeroPointZeroOneDollarsPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForCashAtZeroPointZeroOneDollarsPerUnitMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForCashAtTenDollarPerUnitMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="As_Of_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2011_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2010_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2009_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2008_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2008_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2008_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2008_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2008">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2007_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2007_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2007_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2007_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2007">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2007-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2006_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2006_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2006_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2006_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2006">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2005_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2005_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2005_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2005_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2005">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2005-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2004_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2004">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2003_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2003-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2003_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2003-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2003_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2003-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2003_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2003-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2003">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2003-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2008_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2007_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2006_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2005_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2003_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2003-09-30</instant>
    </period>
  </context>
  <context id="Duration_10_1_2002_To_9_30_2003_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2002_To_9_30_2003_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2002_To_9_30_2003_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2002_To_9_30_2003_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2002_To_9_30_2003_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2002_To_9_30_2003">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_SeriesDPreferredStockIssuedForSubscriptionInUnidymMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:SeriesDPreferredStockIssuedForSubscriptionInUnidymMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_SeriesDPreferredStockIssuedForSubscriptionInUnidymMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:SeriesDPreferredStockIssuedForSubscriptionInUnidymMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_SeriesDPreferredStockIssuedForSubscriptionInUnidymMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:SeriesDPreferredStockIssuedForSubscriptionInUnidymMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_SeriesDPreferredStockIssuedForSubscriptionInUnidymMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:SeriesDPreferredStockIssuedForSubscriptionInUnidymMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_SeriesDPreferredStockIssuedForSubscriptionInUnidymMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:SeriesDPreferredStockIssuedForSubscriptionInUnidymMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_SeriesDPreferredStockIssuedForSubscriptionInUnidymMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:SeriesDPreferredStockIssuedForSubscriptionInUnidymMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="As_Of_11_30_2010_dei_LegalEntityAxis_arwr_UnidymIncMember_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesCPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:UnidymIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-11-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2009_dei_LegalEntityAxis_arwr_UnidymIncMember_us-gaap_StatementClassOfStockAxis_arwr_SeriesC1PreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:UnidymIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:SeriesC1PreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_28_2009_dei_LegalEntityAxis_arwr_UnidymIncMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:UnidymIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-28</instant>
    </period>
  </context>
  <context id="As_Of_9_22_2009_dei_LegalEntityAxis_arwr_UnidymIncMember_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesAPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:UnidymIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-22</instant>
    </period>
  </context>
  <context id="As_Of_6_25_2009_dei_LegalEntityAxis_arwr_UnidymIncMember_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesCPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:UnidymIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-06-25</instant>
    </period>
  </context>
  <context id="As_Of_6_11_2009_dei_LegalEntityAxis_arwr_UnidymIncMember_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesAPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:UnidymIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-06-11</instant>
    </period>
  </context>
  <context id="As_Of_8_8_2008_dei_LegalEntityAxis_arwr_NanoconductionIncMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:NanoconductionIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-08-08</instant>
    </period>
  </context>
  <context id="As_Of_4_20_2007_dei_LegalEntityAxis_arwr_CarbonNanotechnologiesIncMember_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesEPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:CarbonNanotechnologiesIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-04-20</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2009">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_StockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:StockIssuanceCostChargedToAdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_StockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:StockIssuanceCostChargedToAdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_StockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:StockIssuanceCostChargedToAdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_StockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:StockIssuanceCostChargedToAdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_StockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:StockIssuanceCostChargedToAdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_StockIssuanceCostChargedToAdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:StockIssuanceCostChargedToAdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_StockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:StockIssuanceCostChargedToAdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_StockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:StockIssuanceCostChargedToAdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_StockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:StockIssuanceCostChargedToAdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_StockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:StockIssuanceCostChargedToAdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_StockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:StockIssuanceCostChargedToAdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_StockIssuanceCostChargedToAdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:StockIssuanceCostChargedToAdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2006_To_9_30_2007_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2006_To_9_30_2007_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2006_To_9_30_2007_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2006_To_9_30_2007_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2006_To_9_30_2007_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2006_To_9_30_2007">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2005_To_9_30_2006">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2003_To_9_30_2004">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_ArrowheadsIncreaseInProportionateShareOfCalandosEquityMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ArrowheadsIncreaseInProportionateShareOfCalandosEquityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_ArrowheadsIncreaseInProportionateShareOfCalandosEquityMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ArrowheadsIncreaseInProportionateShareOfCalandosEquityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_ArrowheadsIncreaseInProportionateShareOfCalandosEquityMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ArrowheadsIncreaseInProportionateShareOfCalandosEquityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_ArrowheadsIncreaseInProportionateShareOfCalandosEquityMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ArrowheadsIncreaseInProportionateShareOfCalandosEquityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_ArrowheadsIncreaseInProportionateShareOfCalandosEquityMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ArrowheadsIncreaseInProportionateShareOfCalandosEquityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_ArrowheadsIncreaseInProportionateShareOfCalandosEquityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ArrowheadsIncreaseInProportionateShareOfCalandosEquityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2007_To_9_30_2008">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_ArrowheadsIncreaseInProportionateShareOfInsertTherapeuticsEquityMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ArrowheadsIncreaseInProportionateShareOfInsertTherapeuticsEquityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_ArrowheadsIncreaseInProportionateShareOfInsertTherapeuticsEquityMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ArrowheadsIncreaseInProportionateShareOfInsertTherapeuticsEquityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_ArrowheadsIncreaseInProportionateShareOfInsertTherapeuticsEquityMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ArrowheadsIncreaseInProportionateShareOfInsertTherapeuticsEquityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_ArrowheadsIncreaseInProportionateShareOfInsertTherapeuticsEquityMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ArrowheadsIncreaseInProportionateShareOfInsertTherapeuticsEquityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_ArrowheadsIncreaseInProportionateShareOfInsertTherapeuticsEquityMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ArrowheadsIncreaseInProportionateShareOfInsertTherapeuticsEquityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_ArrowheadsIncreaseInProportionateShareOfInsertTherapeuticsEquityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ArrowheadsIncreaseInProportionateShareOfInsertTherapeuticsEquityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2004_To_9_30_2005_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2004_To_9_30_2005_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2004_To_9_30_2005_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2004_To_9_30_2005_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2004_To_9_30_2005_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2004_To_9_30_2005">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2008_To_9_30_2009">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="As_Of_3_31_2011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2011-03-31</instant>
    </period>
  </context>
  <context id="As_Of_12_15_2011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2011-12-15</instant>
    </period>
  </context>
  <context id="As_Of_4_29_2008_dei_LegalEntityAxis_arwr_MasaEnergyLlcMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:MasaEnergyLlcMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-04-29</instant>
    </period>
  </context>
  <context id="As_Of_3_31_2010">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2010-03-31</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2011-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2010">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="Duration_10_1_2010_To_9_30_2011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2009_To_9_30_2010">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="Duration_5_7_2003_To_9_30_2011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2003-05-07</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="As_Of_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTenDollarPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ExercisedAtTenDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtFifteenDollarPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ExercisedAtFifteenDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTwoDollarPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ExercisedAtTwoDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTenDollarPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:ExercisedAtTenDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="As_Of_11_30_2010_dei_LegalEntityAxis_arwr_CalandoPharmaceuticalsIncMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:CalandoPharmaceuticalsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-11-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2010_dei_LegalEntityAxis_arwr_CalandoPharmaceuticalsIncMember_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesAPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:CalandoPharmaceuticalsIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="As_Of_2_28_2010_dei_LegalEntityAxis_arwr_CalandoPharmaceuticalsIncMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:CalandoPharmaceuticalsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-02-28</instant>
    </period>
  </context>
  <context id="As_Of_9_28_2009_dei_LegalEntityAxis_arwr_UnidymIncMember_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesCPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:UnidymIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-28</instant>
    </period>
  </context>
  <context id="As_Of_9_28_2009_dei_LegalEntityAxis_arwr_UnidymIncMember_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesAPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:UnidymIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-28</instant>
    </period>
  </context>
  <context id="As_Of_4_23_2008_dei_LegalEntityAxis_arwr_UnidymIncMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:UnidymIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-04-23</instant>
    </period>
  </context>
  <context id="As_Of_3_31_2006_dei_LegalEntityAxis_arwr_CalandoPharmaceuticalsIncMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:CalandoPharmaceuticalsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-03-31</instant>
    </period>
  </context>
  <context id="As_Of_3_23_2005_dei_LegalEntityAxis_arwr_InsertTherapeuticsIncMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:InsertTherapeuticsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-03-23</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2011_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThreeDollarsAndEightyCentsPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThreeDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirteenDollarsAndTwelveCentsPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThirteenDollarsAndTwelveCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtSixDollarsAndThirtyCentsPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtSixDollarsAndThirtyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThreeDollarsPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThreeDollarsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtApproximatelyEighteenDollarPerShareNetMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtApproximatelyEighteenDollarPerShareNetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirtyFiveDollarsPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThirtyFiveDollarsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFortyEightDollarsAndEightyCentsPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFortyEightDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiftyNineDollarsAndTenCentsPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAtFiftyNineDollarsAndTenCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForMarketableSecuritiesAtTenDollarPerUnitMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForMarketableSecuritiesAtTenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtTenDollarPerUnitMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForCashAtTenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtFifteenDollarPerUnitMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForCashAtFifteenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtZeroPointZeroOneDollarsPerUnitMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForCashAtZeroPointZeroOneDollarsPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2003-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtTenDollarPerUnitMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="arwr:CommonStockIssuanceByTypeAxis">arwr:IssuedForCashAtTenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2003-09-30</instant>
    </period>
  </context>
  <!--Unit Section-->
  <unit id="Unit13">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="Unit12">
    <measure>xbrli:shares</measure>
  </unit>
  <unit id="Unit1">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>xbrli:shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <!--Tuple Section-->
  <!--Element Section-->
  <arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit contextRef="As_Of_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtTenDollarPerUnitMember" unitRef="Unit1" decimals="INF">10</arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit>
  <arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit contextRef="As_Of_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtZeroPointZeroOneDollarsPerUnitMember" unitRef="Unit1" decimals="INF">0.01</arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit>
  <arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit contextRef="As_Of_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember" unitRef="Unit1" decimals="INF">10.9</arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit>
  <arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit contextRef="As_Of_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember" unitRef="Unit1" decimals="INF">15</arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit>
  <arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit contextRef="As_Of_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtFifteenDollarPerUnitMember" unitRef="Unit1" decimals="INF">15</arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit>
  <arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit contextRef="As_Of_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtTenDollarPerUnitMember" unitRef="Unit1" decimals="INF">10</arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit>
  <arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit contextRef="As_Of_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForMarketableSecuritiesAtTenDollarPerUnitMember" unitRef="Unit1" decimals="INF">10</arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit>
  <arwr:CommonStockIssuanceValuePerShare contextRef="As_Of_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember" unitRef="Unit1" decimals="INF">39.8</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare contextRef="As_Of_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiftyNineDollarsAndTenCentsPerShareMember" unitRef="Unit1" decimals="INF">59.1</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare contextRef="As_Of_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFortyEightDollarsAndEightyCentsPerShareMember" unitRef="Unit1" decimals="INF">48.8</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare contextRef="As_Of_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember" unitRef="Unit1" decimals="INF">38.4</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare contextRef="As_Of_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirtyFiveDollarsPerShareMember" unitRef="Unit1" decimals="INF">35</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare contextRef="As_Of_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember" unitRef="Unit1" decimals="INF">51.7</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare contextRef="As_Of_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember" unitRef="Unit1" decimals="INF">57.8</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare contextRef="As_Of_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember" unitRef="Unit1" decimals="INF">37.7</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare contextRef="As_Of_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtApproximatelyEighteenDollarPerShareNetMember" unitRef="Unit1" decimals="INF">18</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare contextRef="As_Of_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember" unitRef="Unit1" decimals="INF">28.3</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare contextRef="As_Of_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember" unitRef="Unit1" decimals="INF">29.5</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare contextRef="As_Of_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember" unitRef="Unit1" decimals="INF">21.8</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare contextRef="As_Of_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember" unitRef="Unit1" decimals="INF">21.9</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare contextRef="As_Of_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember" unitRef="Unit1" decimals="INF">27.2</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare contextRef="As_Of_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember" unitRef="Unit1" decimals="INF">5.5</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare contextRef="As_Of_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember" unitRef="Unit1" decimals="INF">5.2</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare contextRef="As_Of_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThreeDollarsPerShareMember" unitRef="Unit1" decimals="INF">3</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare contextRef="As_Of_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtSixDollarsAndThirtyCentsPerShareMember" unitRef="Unit1" decimals="INF">6.3</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare contextRef="As_Of_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirteenDollarsAndTwelveCentsPerShareMember" unitRef="Unit1" decimals="INF">13.12</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare contextRef="As_Of_9_30_2011_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThreeDollarsAndEightyCentsPerShareMember" unitRef="Unit1" decimals="2">3.80</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockPurchasedFromMinorityShareHolders contextRef="As_Of_3_23_2005_dei_LegalEntityAxis_arwr_InsertTherapeuticsIncMember" unitRef="Unit12" decimals="0">7375000</arwr:CommonStockPurchasedFromMinorityShareHolders>
  <arwr:CommonStockPurchasedFromMinorityShareHolders contextRef="As_Of_3_31_2006_dei_LegalEntityAxis_arwr_CalandoPharmaceuticalsIncMember" unitRef="Unit12" decimals="0">964000</arwr:CommonStockPurchasedFromMinorityShareHolders>
  <arwr:CommonStockPurchasedFromMinorityShareHolders contextRef="As_Of_4_23_2008_dei_LegalEntityAxis_arwr_UnidymIncMember" unitRef="Unit12" decimals="0">200000</arwr:CommonStockPurchasedFromMinorityShareHolders>
  <arwr:CommonStockPurchasedFromMinorityShareHolders contextRef="As_Of_9_28_2009_dei_LegalEntityAxis_arwr_UnidymIncMember_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesAPreferredStockMember" unitRef="Unit12" decimals="0">5574</arwr:CommonStockPurchasedFromMinorityShareHolders>
  <arwr:CommonStockPurchasedFromMinorityShareHolders contextRef="As_Of_9_28_2009_dei_LegalEntityAxis_arwr_UnidymIncMember_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesCPreferredStockMember" unitRef="Unit12" decimals="0">636699</arwr:CommonStockPurchasedFromMinorityShareHolders>
  <arwr:CommonStockPurchasedFromMinorityShareHolders contextRef="As_Of_2_28_2010_dei_LegalEntityAxis_arwr_CalandoPharmaceuticalsIncMember" unitRef="Unit12" decimals="0">200000</arwr:CommonStockPurchasedFromMinorityShareHolders>
  <arwr:CommonStockPurchasedFromMinorityShareHolders contextRef="As_Of_9_30_2010_dei_LegalEntityAxis_arwr_CalandoPharmaceuticalsIncMember_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesAPreferredStockMember" unitRef="Unit12" decimals="1">1562.5</arwr:CommonStockPurchasedFromMinorityShareHolders>
  <arwr:CommonStockPurchasedFromMinorityShareHolders contextRef="As_Of_11_30_2010_dei_LegalEntityAxis_arwr_CalandoPharmaceuticalsIncMember" unitRef="Unit12" decimals="0">2850000</arwr:CommonStockPurchasedFromMinorityShareHolders>
  <arwr:ExerciseOfStockOptionsPricePerShare contextRef="As_Of_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTenDollarPerShareMember" unitRef="Unit1" decimals="INF">10</arwr:ExerciseOfStockOptionsPricePerShare>
  <arwr:ExerciseOfStockOptionsPricePerShare contextRef="As_Of_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTwoDollarPerShareMember" unitRef="Unit1" decimals="INF">2</arwr:ExerciseOfStockOptionsPricePerShare>
  <arwr:ExerciseOfStockOptionsPricePerShare contextRef="As_Of_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtFifteenDollarPerShareMember" unitRef="Unit1" decimals="INF">15</arwr:ExerciseOfStockOptionsPricePerShare>
  <arwr:ExerciseOfStockOptionsPricePerShare contextRef="As_Of_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTenDollarPerShareMember" unitRef="Unit1" decimals="INF">10</arwr:ExerciseOfStockOptionsPricePerShare>
  <arwr:ExercisePriceOfWarrants contextRef="As_Of_2_28_2010_dei_LegalEntityAxis_arwr_CalandoPharmaceuticalsIncMember" unitRef="Unit1" decimals="2">5.00</arwr:ExercisePriceOfWarrants>
  <arwr:ExercisePriceOfWarrants contextRef="As_Of_9_30_2010_dei_LegalEntityAxis_arwr_CalandoPharmaceuticalsIncMember_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesAPreferredStockMember" unitRef="Unit1" decimals="2">5.00</arwr:ExercisePriceOfWarrants>
  <arwr:GainLossFromSaleOfSubsidiary contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">306344</arwr:GainLossFromSaleOfSubsidiary>
  <arwr:GainLossOnSaleOfStockInSubsidiary contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">2292800</arwr:GainLossOnSaleOfStockInSubsidiary>
  <arwr:GainOnRenegotiationOfAccruedSeverance contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">726500</arwr:GainOnRenegotiationOfAccruedSeverance>
  <arwr:NoncontrollingInterest contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">17834490</arwr:NoncontrollingInterest>
  <arwr:NoncontrollingInterest contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">1182990</arwr:NoncontrollingInterest>
  <arwr:NoncontrollingInterest contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">363514</arwr:NoncontrollingInterest>
  <arwr:ProceedsFromSaleOfStockInSubsidiary contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">20894100</arwr:ProceedsFromSaleOfStockInSubsidiary>
  <arwr:ProceedsFromSaleOfStockInSubsidiary contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">1718932</arwr:ProceedsFromSaleOfStockInSubsidiary>
  <arwr:ResearchEquipment contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">752850</arwr:ResearchEquipment>
  <arwr:ResearchEquipment contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">3515</arwr:ResearchEquipment>
  <arwr:StockIssuedAgainstWarrants contextRef="As_Of_3_31_2010" unitRef="Unit12" decimals="0">12870</arwr:StockIssuedAgainstWarrants>
  <arwr:StockIssuedAsGift contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">298750</arwr:StockIssuedAsGift>
  <arwr:StockIssuedForInProcessResearchAndDevelopment contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">13166347</arwr:StockIssuedForInProcessResearchAndDevelopment>
  <arwr:ValueOfCommonStockPurchasedByCash contextRef="As_Of_3_31_2006_dei_LegalEntityAxis_arwr_CalandoPharmaceuticalsIncMember" unitRef="Unit13" decimals="0">850667</arwr:ValueOfCommonStockPurchasedByCash>
  <arwr:ValueOfCommonStockPurchasedByCash contextRef="As_Of_4_29_2008_dei_LegalEntityAxis_arwr_MasaEnergyLlcMember" unitRef="Unit13" decimals="0">250000</arwr:ValueOfCommonStockPurchasedByCash>
  <arwr:ValueOfCommonStockPurchasedFromMinorityShareHolders contextRef="As_Of_3_31_2006_dei_LegalEntityAxis_arwr_CalandoPharmaceuticalsIncMember" unitRef="Unit13" decimals="0">1928000</arwr:ValueOfCommonStockPurchasedFromMinorityShareHolders>
  <arwr:ValueOfCommonStockPurchasedFromMinorityShareHolders contextRef="As_Of_4_23_2008_dei_LegalEntityAxis_arwr_UnidymIncMember" unitRef="Unit13" decimals="0">200000</arwr:ValueOfCommonStockPurchasedFromMinorityShareHolders>
  <arwr:ValueOfCommonStockPurchasedFromMinorityShareHolders contextRef="As_Of_4_29_2008_dei_LegalEntityAxis_arwr_MasaEnergyLlcMember" unitRef="Unit13" decimals="0">560000</arwr:ValueOfCommonStockPurchasedFromMinorityShareHolders>
  <arwr:WarrantsExercised contextRef="As_Of_3_31_2010" unitRef="Unit12" decimals="0">24788</arwr:WarrantsExercised>
  <arwr:WarrantsIssued contextRef="As_Of_2_28_2010_dei_LegalEntityAxis_arwr_CalandoPharmaceuticalsIncMember" unitRef="Unit12" decimals="0">2400</arwr:WarrantsIssued>
  <arwr:WarrantsIssued contextRef="As_Of_9_30_2010_dei_LegalEntityAxis_arwr_CalandoPharmaceuticalsIncMember_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesAPreferredStockMember" unitRef="Unit12" decimals="0">390625</arwr:WarrantsIssued>
  <arwr:WarrantsIssued contextRef="As_Of_11_30_2010_dei_LegalEntityAxis_arwr_CalandoPharmaceuticalsIncMember" unitRef="Unit12" decimals="0">24000</arwr:WarrantsIssued>
  <arwr:WarrantsPurchased contextRef="As_Of_2_28_2010_dei_LegalEntityAxis_arwr_CalandoPharmaceuticalsIncMember" unitRef="Unit12" decimals="0">60000</arwr:WarrantsPurchased>
  <arwr:WarrantsPurchased contextRef="As_Of_11_30_2010_dei_LegalEntityAxis_arwr_CalandoPharmaceuticalsIncMember" unitRef="Unit12" decimals="0">600000</arwr:WarrantsPurchased>
  <dei:AmendmentFlag contextRef="Duration_10_1_2010_To_9_30_2011">false</dei:AmendmentFlag>
  <dei:CurrentFiscalYearEndDate contextRef="Duration_10_1_2010_To_9_30_2011">--09-30</dei:CurrentFiscalYearEndDate>
  <dei:DocumentFiscalPeriodFocus contextRef="Duration_10_1_2010_To_9_30_2011">FY</dei:DocumentFiscalPeriodFocus>
  <dei:DocumentFiscalYearFocus contextRef="Duration_10_1_2010_To_9_30_2011">2011</dei:DocumentFiscalYearFocus>
  <dei:DocumentPeriodEndDate contextRef="Duration_10_1_2010_To_9_30_2011">2011-09-30</dei:DocumentPeriodEndDate>
  <dei:DocumentType contextRef="Duration_10_1_2010_To_9_30_2011">10-K</dei:DocumentType>
  <dei:EntityCentralIndexKey contextRef="Duration_10_1_2010_To_9_30_2011">0000879407</dei:EntityCentralIndexKey>
  <dei:EntityCommonStockSharesOutstanding contextRef="As_Of_12_15_2011" unitRef="Unit12" decimals="0">10525941</dei:EntityCommonStockSharesOutstanding>
  <dei:EntityCurrentReportingStatus contextRef="Duration_10_1_2010_To_9_30_2011">Yes</dei:EntityCurrentReportingStatus>
  <dei:EntityFilerCategory contextRef="Duration_10_1_2010_To_9_30_2011">Smaller Reporting Company</dei:EntityFilerCategory>
  <dei:EntityPublicFloat contextRef="As_Of_3_31_2011" unitRef="Unit13" decimals="-6">53000000</dei:EntityPublicFloat>
  <dei:EntityRegistrantName contextRef="Duration_10_1_2010_To_9_30_2011">ARROWHEAD RESEARCH CORP</dei:EntityRegistrantName>
  <dei:EntityVoluntaryFilers contextRef="Duration_10_1_2010_To_9_30_2011">No</dei:EntityVoluntaryFilers>
  <dei:EntityWellKnownSeasonedIssuer contextRef="Duration_10_1_2010_To_9_30_2011">No</dei:EntityWellKnownSeasonedIssuer>
  <us-gaap:AccountsPayableCurrent contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">681563</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccountsPayableCurrent contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">576809</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccountsReceivableNetCurrent contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">58864</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">494736</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">864511</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">1176404</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">340364</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">119716834</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">127476435</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="Duration_10_1_2008_To_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">163960</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="Duration_10_1_2008_To_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" decimals="0">-163960</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt contextRef="Duration_10_1_2008_To_9_30_2009" unitRef="Unit13" decimals="0">2000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt contextRef="Duration_10_1_2008_To_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">2000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest contextRef="Duration_10_1_2004_To_9_30_2005" unitRef="Unit13" decimals="0">230087</us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest xsi:nil="true" contextRef="Duration_10_1_2004_To_9_30_2005_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest contextRef="Duration_10_1_2004_To_9_30_2005_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">230087</us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest xsi:nil="true" contextRef="Duration_10_1_2004_To_9_30_2005_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest xsi:nil="true" contextRef="Duration_10_1_2004_To_9_30_2005_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest xsi:nil="true" contextRef="Duration_10_1_2004_To_9_30_2005_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest contextRef="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_ArrowheadsIncreaseInProportionateShareOfInsertTherapeuticsEquityMember" unitRef="Unit13" decimals="0">2401394</us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest xsi:nil="true" contextRef="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_ArrowheadsIncreaseInProportionateShareOfInsertTherapeuticsEquityMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest contextRef="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_ArrowheadsIncreaseInProportionateShareOfInsertTherapeuticsEquityMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">2401394</us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest xsi:nil="true" contextRef="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_ArrowheadsIncreaseInProportionateShareOfInsertTherapeuticsEquityMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest xsi:nil="true" contextRef="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_ArrowheadsIncreaseInProportionateShareOfInsertTherapeuticsEquityMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest xsi:nil="true" contextRef="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_ArrowheadsIncreaseInProportionateShareOfInsertTherapeuticsEquityMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest contextRef="Duration_10_1_2007_To_9_30_2008" unitRef="Unit13" decimals="0">1720962</us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest contextRef="Duration_10_1_2007_To_9_30_2008_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">1720962</us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest contextRef="Duration_10_1_2008_To_9_30_2009" unitRef="Unit13" decimals="0">16297</us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_ArrowheadsIncreaseInProportionateShareOfCalandosEquityMember" unitRef="Unit13" decimals="0">2120250</us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest contextRef="Duration_10_1_2008_To_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">16297</us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_ArrowheadsIncreaseInProportionateShareOfCalandosEquityMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_ArrowheadsIncreaseInProportionateShareOfCalandosEquityMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">2120250</us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_ArrowheadsIncreaseInProportionateShareOfCalandosEquityMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_ArrowheadsIncreaseInProportionateShareOfCalandosEquityMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_ArrowheadsIncreaseInProportionateShareOfCalandosEquityMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">245345</us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" decimals="0">54655</us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">-849707</us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" decimals="0">849707</us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="Duration_10_1_2003_To_9_30_2004" unitRef="Unit13" decimals="0">175653</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">175653</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="Duration_10_1_2004_To_9_30_2005" unitRef="Unit13" decimals="0">508513</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2004_To_9_30_2005_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="Duration_10_1_2004_To_9_30_2005_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">508513</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2004_To_9_30_2005_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2004_To_9_30_2005_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2004_To_9_30_2005_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="Duration_10_1_2005_To_9_30_2006" unitRef="Unit13" decimals="0">1369478</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2005_To_9_30_2006_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="Duration_10_1_2005_To_9_30_2006_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">1369478</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2005_To_9_30_2006_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2005_To_9_30_2006_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2005_To_9_30_2006_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="Duration_10_1_2006_To_9_30_2007" unitRef="Unit13" decimals="0">2175544</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2006_To_9_30_2007_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="Duration_10_1_2006_To_9_30_2007_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">2175544</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2006_To_9_30_2007_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2006_To_9_30_2007_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2006_To_9_30_2007_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="Duration_10_1_2007_To_9_30_2008" unitRef="Unit13" decimals="0">3187397</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="Duration_10_1_2007_To_9_30_2008_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">3187397</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="Duration_10_1_2008_To_9_30_2009" unitRef="Unit13" decimals="0">2676170</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="Duration_10_1_2008_To_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">2676170</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">1582149</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">1582149</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">1404640</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">1404640</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_StockIssuanceCostChargedToAdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">-168000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts xsi:nil="true" contextRef="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_StockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_StockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">-168000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts xsi:nil="true" contextRef="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_StockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts xsi:nil="true" contextRef="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_StockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts xsi:nil="true" contextRef="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_StockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="Duration_10_1_2003_To_9_30_2004" unitRef="Unit13" decimals="0">-991318</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_StockIssuanceCostChargedToAdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">-96500</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">-991318</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_StockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_StockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">-96500</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_StockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_StockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_StockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">90789</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
  <us-gaap:AmortizationOfDebtDiscountPremium contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">-7938</us-gaap:AmortizationOfDebtDiscountPremium>
  <us-gaap:AmortizationOfDebtDiscountPremium contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">-7938</us-gaap:AmortizationOfDebtDiscountPremium>
  <us-gaap:AmortizationOfIntangibleAssets contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">1781944</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:AmortizationOfIntangibleAssets contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">241808</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:AmortizationOfIntangibleAssets contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">241808</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:Assets contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">12354542</us-gaap:Assets>
  <us-gaap:Assets contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">15888563</us-gaap:Assets>
  <us-gaap:AssetsCurrent contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">8131775</us-gaap:AssetsCurrent>
  <us-gaap:AssetsCurrent contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">9861174</us-gaap:AssetsCurrent>
  <us-gaap:CapitalizedComputerSoftwareGross contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">150445</us-gaap:CapitalizedComputerSoftwareGross>
  <us-gaap:CapitalizedComputerSoftwareGross contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">77020</us-gaap:CapitalizedComputerSoftwareGross>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="As_Of_9_30_2009" unitRef="Unit13" decimals="0">2020224</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">6847162</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">7507389</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">7507389</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">4826938</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">660227</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashDivestedFromDeconsolidation contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">1700398</us-gaap:CashDivestedFromDeconsolidation>
  <us-gaap:CashDivestedFromDeconsolidation xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" />
  <us-gaap:CashDivestedFromDeconsolidation contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">1700398</us-gaap:CashDivestedFromDeconsolidation>
  <us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">-1677000</us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations>
  <us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">-126534</us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations>
  <us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">790625</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
  <us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">487593</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
  <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">-46003507</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
  <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">-2645860</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
  <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">2265284</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
  <us-gaap:CommitmentsAndContingencies xsi:nil="true" contextRef="As_Of_9_30_2010" unitRef="Unit13" />
  <us-gaap:CommitmentsAndContingencies xsi:nil="true" contextRef="As_Of_9_30_2011" unitRef="Unit13" />
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="As_Of_9_30_2010" unitRef="Unit1" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="As_Of_9_30_2011" unitRef="Unit1" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized contextRef="As_Of_9_30_2010" unitRef="Unit12" decimals="INF">145000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesAuthorized contextRef="As_Of_9_30_2011" unitRef="Unit12" decimals="INF">145000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued contextRef="As_Of_3_23_2005_dei_LegalEntityAxis_arwr_InsertTherapeuticsIncMember" unitRef="Unit12" decimals="0">50226</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued contextRef="As_Of_3_31_2006_dei_LegalEntityAxis_arwr_CalandoPharmaceuticalsIncMember" unitRef="Unit12" decimals="0">20838</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued contextRef="As_Of_4_20_2007_dei_LegalEntityAxis_arwr_CarbonNanotechnologiesIncMember_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesEPreferredStockMember" unitRef="Unit12" decimals="0">143122</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued contextRef="As_Of_4_23_2008_dei_LegalEntityAxis_arwr_UnidymIncMember" unitRef="Unit12" decimals="0">7054</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued contextRef="As_Of_4_29_2008_dei_LegalEntityAxis_arwr_MasaEnergyLlcMember" unitRef="Unit12" decimals="0">10504</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued contextRef="As_Of_8_8_2008_dei_LegalEntityAxis_arwr_NanoconductionIncMember" unitRef="Unit12" decimals="0">11411</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued contextRef="As_Of_6_11_2009_dei_LegalEntityAxis_arwr_UnidymIncMember_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesAPreferredStockMember" unitRef="Unit12" decimals="0">132462</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued contextRef="As_Of_6_25_2009_dei_LegalEntityAxis_arwr_UnidymIncMember_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesCPreferredStockMember" unitRef="Unit12" decimals="0">194444</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued contextRef="As_Of_9_22_2009_dei_LegalEntityAxis_arwr_UnidymIncMember_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesAPreferredStockMember" unitRef="Unit12" decimals="0">9149</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued contextRef="As_Of_9_28_2009_dei_LegalEntityAxis_arwr_UnidymIncMember" unitRef="Unit12" decimals="0">64227</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued contextRef="As_Of_9_30_2009_dei_LegalEntityAxis_arwr_UnidymIncMember_us-gaap_StatementClassOfStockAxis_arwr_SeriesC1PreferredStockMember" unitRef="Unit12" decimals="0">27777</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued contextRef="As_Of_2_28_2010_dei_LegalEntityAxis_arwr_CalandoPharmaceuticalsIncMember" unitRef="Unit12" decimals="0">8000</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued contextRef="As_Of_9_30_2010" unitRef="Unit12" decimals="INF">7172014</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued contextRef="As_Of_11_30_2010_dei_LegalEntityAxis_arwr_CalandoPharmaceuticalsIncMember" unitRef="Unit12" decimals="0">114000</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued contextRef="As_Of_11_30_2010_dei_LegalEntityAxis_arwr_UnidymIncMember_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesCPreferredStockMember" unitRef="Unit12" decimals="0">15317</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued contextRef="As_Of_9_30_2011" unitRef="Unit12" decimals="INF">8642286</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding contextRef="As_Of_9_30_2010" unitRef="Unit12" decimals="INF">7172014</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding contextRef="As_Of_9_30_2011" unitRef="Unit12" decimals="INF">8642286</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockValue contextRef="As_Of_3_23_2005_dei_LegalEntityAxis_arwr_InsertTherapeuticsIncMember" unitRef="Unit13" decimals="0">2000000</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue contextRef="As_Of_3_31_2006_dei_LegalEntityAxis_arwr_CalandoPharmaceuticalsIncMember" unitRef="Unit13" decimals="0">1077333</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue contextRef="As_Of_4_20_2007_dei_LegalEntityAxis_arwr_CarbonNanotechnologiesIncMember_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesEPreferredStockMember" unitRef="Unit13" decimals="0">5400000</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue contextRef="As_Of_4_29_2008_dei_LegalEntityAxis_arwr_MasaEnergyLlcMember" unitRef="Unit13" decimals="0">310000</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue contextRef="As_Of_8_8_2008_dei_LegalEntityAxis_arwr_NanoconductionIncMember" unitRef="Unit13" decimals="0">250000</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue contextRef="As_Of_6_11_2009_dei_LegalEntityAxis_arwr_UnidymIncMember_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesAPreferredStockMember" unitRef="Unit13" decimals="0">688802</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue contextRef="As_Of_6_25_2009_dei_LegalEntityAxis_arwr_UnidymIncMember_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesCPreferredStockMember" unitRef="Unit13" decimals="0">972222</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue contextRef="As_Of_9_22_2009_dei_LegalEntityAxis_arwr_UnidymIncMember_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesAPreferredStockMember" unitRef="Unit13" decimals="0">46662</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue contextRef="As_Of_9_28_2009_dei_LegalEntityAxis_arwr_UnidymIncMember" unitRef="Unit13" decimals="0">398209</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue contextRef="As_Of_9_30_2009_dei_LegalEntityAxis_arwr_UnidymIncMember_us-gaap_StatementClassOfStockAxis_arwr_SeriesC1PreferredStockMember" unitRef="Unit13" decimals="0">186111</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">71735</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue contextRef="As_Of_11_30_2010_dei_LegalEntityAxis_arwr_CalandoPharmaceuticalsIncMember" unitRef="Unit13" decimals="0">706800</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue contextRef="As_Of_11_30_2010_dei_LegalEntityAxis_arwr_UnidymIncMember_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesCPreferredStockMember" unitRef="Unit13" decimals="0">47485</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">86423</us-gaap:CommonStockValue>
  <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock contextRef="Duration_10_1_2010_To_9_30_2011">&lt;div&gt; &lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;
&lt;/font&gt;
&lt;div&gt;

&lt;p style="margin-top: 18px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&lt;b&gt;NOTE 11. &lt;/b&gt;&lt;b&gt;&lt;i&gt;EMPLOYEE BENEFIT PLANS &lt;/i&gt;&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 6px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;In January 2005, the Company began sponsoring a defined contribution 401(k) retirement savings plan covering substantially all of its employees. The Plan was administered under the "safe harbor" provision of ERISA. Under the terms of the plan, an eligible employee may elect to contribute a portion of their salary on a pre-tax basis, subject to federal statutory limitations. The plan allowed for a discretionary match in an amount up to 100% of each participant's first 3% of compensation contributed plus 50% of each participant's next 2% of compensation contributed. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; margin-bottom: 0px; font-size: 1px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="margin-top: 0px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;For the years ended September 30, 2011 and 2010, we recorded expenses under these plans of approximately $43,000 and $9,000, respectively and $448,000 since inception of the Company. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;In addition to the employee benefit plans described above, the Company participates in certain customary employee benefits plans, including those which provide health and life insurance benefits to employees.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
  <us-gaap:CostMethodInvestments contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">187000</us-gaap:CostMethodInvestments>
  <us-gaap:CostMethodInvestments contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">187000</us-gaap:CostMethodInvestments>
  <us-gaap:DebtDisclosureTextBlock contextRef="Duration_10_1_2010_To_9_30_2011">&lt;div&gt; &lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;
&lt;/font&gt;
&lt;div&gt;

&lt;p style="margin-top: 18px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&lt;b&gt;NOTE 4. &lt;/b&gt;&lt;b&gt;&lt;i&gt;NOTES PAYABLE &lt;/i&gt;&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 6px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;On November 26, 2008, Calando entered into Unsecured Convertible Promissory Note Agreements ("Notes") for $2.5 million with accredited investors and Arrowhead, which invested $200,000 in the Notes offering. Arrowhead subsequently invested an additional $600,000 in the same offering. Except for one Note in the principal amount of $500,000, all Notes and accrued interest were converted into a total of 2,950 shares of Calando Series A Preferred Stock on June 23, 2009. The remaining Note had a 10% interest rate, matured on November 26, 2010, and was renegotiated and extended until November 26, 2013. The terms of the new note include a 10% interest rate and require two times principal payment upon certain events as defined in the note and at maturity.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
  <us-gaap:DeferredRentReceivablesNetNoncurrent contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">34735</us-gaap:DeferredRentReceivablesNetNoncurrent>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">5660311</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">277650</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">267977</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DerivativeAssetsNoncurrent contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">161125</us-gaap:DerivativeAssetsNoncurrent>
  <us-gaap:DerivativeLiabilitiesCurrent contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">2408522</us-gaap:DerivativeLiabilitiesCurrent>
  <us-gaap:DerivativeLiabilitiesCurrent contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">944980</us-gaap:DerivativeLiabilitiesCurrent>
  <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock contextRef="Duration_10_1_2010_To_9_30_2011">&lt;div&gt; &lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;
&lt;/font&gt;
&lt;div&gt;

&lt;p style="margin-top: 18px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&lt;b&gt;NOTE 7. &lt;/b&gt;&lt;b&gt;&lt;i&gt;STOCK-BASED COMPENSATION&lt;/i&gt;&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 6px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Arrowhead has two plans that provide for equity-based compensation. Under the 2000 Stock Option Plan, 153,200 shares of Arrowhead's Common Stock are reserved for issuance upon exercise of non-qualified stock options. No further grants can be made under the 2000 Stock Option Plan. The 2004 Equity Incentive Plan reserves 970,443 shares for the grant of stock options, stock appreciation rights, restricted stock awards and performance unit/share awards by the Board of Directors to employees, consultants and others. As of September 30, 2011, there were options granted and outstanding to purchase 153,200 and 575,896 shares of Common Stock under the 2000 Stock Option Plan and the 2004 Equity Incentive Plan, respectively. During the year ended September 30, 2011, 20,000 options were granted under the 2004 Equity Incentive Plan. All share and per share data in this footnote has been adjusted to reflect the 1 for 10 reverse stock split effected on November 17, 2011. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;The following tables summarize information about stock options: &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 0px; margin-bottom: 0px; font-size: 12px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"&gt;
&lt;tr&gt;&lt;td width="70%"&gt; &lt;/td&gt;
&lt;td valign="bottom" width="3%"&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td valign="bottom" width="3%"&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td valign="bottom" width="3%"&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td valign="bottom" width="3%"&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;Number of&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;Options&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;Weighted-&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;Per&amp;nbsp;Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;Weighted-&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;Term&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;Intrinsic&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Balance At September&amp;nbsp;30, 2009&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;290,158&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;17.35&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;525,175&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;6.88&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Cancelled&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;(2,312&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;)&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;11.10&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Exercised&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;(687&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;)&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;11.10&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;nbsp;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;nbsp;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;nbsp;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Balance At September&amp;nbsp;30, 2010&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;812,334&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;10.62&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;20,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;5.86&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Cancelled&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;(100,539&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;)&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;21.32&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Exercised&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;(2,699&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;)&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;5.10&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;nbsp;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;nbsp;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;nbsp;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Balance At September&amp;nbsp;30, 2011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;729,096&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;9.03&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;7.0&amp;nbsp;years&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;#8212;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;nbsp;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;nbsp;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;nbsp;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Exercisable At September, 30, 2011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;570,307&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;9.39&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;6.6 years&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;#8212;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;nbsp;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;nbsp;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;nbsp;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 12px; margin-bottom: 0px; font-size: 1px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="margin-top: 0px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Stock-based compensation expense for the years ended September 30, 2011 and 2010 was $1,404,430 and $1,582,149, respectively. For the year ended September 30, 2011 and 2010, $27,519 and $157,856, respectively, of this expense is included in discontinued operations, and the balance is included in Salary expense in the Company's consolidated statements of operations. There is no income tax benefit as the company is currently operating at a loss and an actual income tax benefit may not be realized. The result of the loss creates a timing difference, resulting in a deferred tax asset, which is fully reserved by a valuation allowance. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;The fair value of the options granted by Arrowhead for the years ended September 30, 2011 and 2010 is estimated at $93,004 and $2,939,928, respectively. The aggregate fair value of options granted by Calando for the years ended September 30, 2011 is estimated at $33,870. No Calando options were issued during the year ended September 30, 2010. The intrinsic value of the options exercised during fiscal 2011 and 2010 was $3,666 and $6,875, respectively. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;As of September 30, 2011, the pre-tax compensation expense for all unvested stock options at Arrowhead in the amount of approximately $1,091,513 will be recognized in our results of operations over a weighted average period of 2.4 years. As of September 30, 2011, the pre-tax compensation expense for all unvested stock options at Calando in the amount of approximately $69,183 will be recognized in our results of operations over a weighted average period of 2.8 years. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;The fair value of each stock option award is estimated on the date of grant using the Black-Scholes option pricing model. The Black-Scholes option valuation model was developed for use in estimating the fair value of traded options, which do not have vesting restrictions and are fully transferable. The determination of the fair value of each stock option is affected by our stock price on the date of grant, as well as assumptions regarding a number of highly complex and subjective variables. Because the Company's employee stock options have characteristics significantly different from those of traded options, and because changes in the subjective input assumptions can materially affect the fair value estimate, in management's opinion, the existing models do not necessarily provide a reliable single measure of the fair value of its employee stock options. The assumptions used to value stock options are as follows: &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 0px; margin-bottom: 0px; font-size: 12px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"&gt;
&lt;tr&gt;&lt;td width="70%"&gt; &lt;/td&gt;
&lt;td valign="bottom" width="12%"&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td valign="bottom" width="12%"&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="6" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;Year Ended September&amp;nbsp;30,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;2010&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Dividend yield&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;#8212;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;#8212;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Risk-free interest rate&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;1.11%&amp;nbsp;to&amp;nbsp;2.90%&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;2.00%&amp;nbsp;to&amp;nbsp;3.42%&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Volatility&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;100%&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;100%&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Expected life (in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;5.5 to 6.25&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;5 to 6.25&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Weighted average grant date fair value per share of options granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$4.70&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$5.60&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;The dividend yield is zero as the Company currently does not pay a dividend. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;The risk-free interest rate is based on the U.S. Treasury bond. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Volatility is estimated based on volatility average of the Company's Common Stock price.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
  <us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">4708588</us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax>
  <us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">3919213</us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax>
  <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">42837974</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
  <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">2645051</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
  <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">-5292609</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
  <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">-47546562</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax>
  <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">-2645051</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax>
  <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">1373396</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax>
  <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock contextRef="Duration_10_1_2010_To_9_30_2011">&lt;div&gt; &lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;
&lt;/font&gt;
&lt;div&gt;

&lt;p style="margin-top: 0px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&lt;b&gt;NOTE 3. &lt;/b&gt;&lt;b&gt;&lt;i&gt;DISCONTINUED OPERATIONS &lt;/i&gt;&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 6px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&lt;i&gt;Unidym, Inc. &lt;/i&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 6px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Founded by Arrowhead in 2005, Unidym is developing electronic applications of carbon nanotubes. In line with the Company's strategy to focus on nanomedicine, Arrowhead sold its ownership interest in Unidym to Wisepower in January 2011. The consideration included $5.0 million in Wisepower stock and bonds, a percentage of certain revenue streams, as well as contingent payments up to $140 million based on revenue milestones over a ten-year period. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;In conjunction with the disposition of Unidym, the gain on the sale and the results of historical operations are recorded as discontinued operations in the Company's Statements of Operations. Additionally, the cash flows from Unidym are reflected separately as cash flows from discontinued operations. Potential future cash flows as discussed above will be reflected as a part of cash flows from discontinued operations in the Company's Consolidated Statements of Cash Flows. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 18px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&lt;i&gt;Tego Biosciences, Inc. &lt;/i&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 6px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;On April 20, 2007, Tego, a wholly-owned subsidiary of Arrowhead, acquired the assets of C Sixty, Inc., a Texas-based company developing protective products based on the anti-oxidant properties of fullerenes. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;On December 23, 2009, Tego completed the sale of all of its non-cash intellectual property assets to Luna Innovations, Inc. The consideration included an upfront purchase price of $350,000 and reimbursements of patent and license expenses of $80,000, as well as contingent payments based on milestones and royalties for each fullerene product developed by Luna and covered by Tego intellectual property. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Due to the sale of substantially all of Tego's assets, the operations of Tego ceased and the gain on the sale and the results of historical operations are recorded as discontinued operation in the Company's Statements of Operations. Additionally, the cash flows from Tego are reflected separately as cash flows from discontinued operations. Potential future cash flows associated with the Luna APA, as discussed above, will be reflected as a part of cash flows from discontinued operations in the Company's Consolidated Statements of Cash Flows.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
  <us-gaap:EarningsPerShareBasic contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit1" decimals="2">-0.90</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareBasic contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit1" decimals="2">-0.44</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareDiluted contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit1" decimals="2">-0.90</us-gaap:EarningsPerShareDiluted>
  <us-gaap:EarningsPerShareDiluted contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit1" decimals="2">-0.40</us-gaap:EarningsPerShareDiluted>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">191425</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">195649</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:EquityMethodInvestments contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">1812927</us-gaap:EquityMethodInvestments>
  <us-gaap:EquityMethodInvestments contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">1649748</us-gaap:EquityMethodInvestments>
  <us-gaap:EquityMethodInvestmentsDisclosureTextBlock contextRef="Duration_10_1_2010_To_9_30_2011">&lt;div&gt; &lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;
&lt;/font&gt;
&lt;div&gt;

&lt;p style="margin-top: 18px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&lt;b&gt;NOTE 2. &lt;/b&gt;&lt;i&gt; &lt;/i&gt;&lt;b&gt;&lt;i&gt;INVESTMENT IN SUBSIDIARIES&lt;/i&gt;&lt;/b&gt;&lt;i&gt; &lt;/i&gt;&lt;b&gt; &lt;/b&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 6px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&lt;i&gt;Calando Pharmaceuticals, Inc. (formerly known as Insert Therapeutics, Inc.) &lt;/i&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 6px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;On April 17, 2008, Calando merged with and into Insert, with Insert as the surviving company. Prior to the merger, Arrowhead invested an aggregate of $23.2 million in Calando through equity and debt financings. As a condition of the merger, the Preferred Stock of each of Calando and Insert was converted into common stock and the loans were converted to equity. As a result of the merger, shares of Insert common stock were issued to the stockholders of the former Calando, and Insert changed its name to Calando Pharmaceuticals, Inc. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;On November 26, 2008, Calando entered into Unsecured Convertible Promissory Note Agreements ("Notes") for $2.5 million with accredited investors and Arrowhead, which invested $200,000 in the Notes offering. Arrowhead subsequently invested an additional $600,000 in the same offering. Subsequently, most of the Notes were converted to equity as described below. At September 30, 2011 and 2010, one Note for $500,000 remained outstanding. The Notes had a 10% interest rate and matured on November 26, 2010. The $500,000 remaining Note is convertible into Calando common stock and can be redeemed for two times their face value plus interest in the event of a sale of Calando or at maturity. To facilitate this investment in Calando, Arrowhead subordinated a series of 6% simple interest loans and advances totaling approximately $5.3 million of principal plus interest. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Effective June 23, 2009, to facilitate licensing transactions with a third party, holders (including Arrowhead) of an aggregate of $2.9 million of the Notes, including accrued but unpaid interest, converted the principal and accrued interest into newly authorized Calando Series A Preferred Stock. The non-voting Series A Preferred Stock has a liquidation preference of 2.5 times the Series A Original Issue Price of $1,000 per share and is convertible into common stock at a conversion price of $0.576647 per share. Arrowhead converted all of its Notes representing a principal balance of $800,000, plus accrued but unpaid interest, into 829 shares of Series A Preferred Stock. One third-party Note for $500,000 plus interest remains outstanding. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;As of September 30, 2011, Arrowhead had a 10% simple-interest working promissory note and advances outstanding to Calando totaling $907,501, which are payable upon demand. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; margin-bottom: 0px; font-size: 1px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="margin-top: 0px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;In fiscal 2010, Arrowhead issued 122,000 shares of its Common Stock in exchange for 3,050,000 shares of Calando common stock, with several minority stockholders of Calando. In conjunction with this exchange, Arrowhead also issued 26,400 warrants to purchase Arrowhead Common Stock in exchange for 660,000 warrants to purchase Calando common stock. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;In January 2011, Arrowhead invested $9.1 million, through a cash investment of $1.0 million and the conversion of $8.1 million intercompany debt, acquiring newly issued Calando Series B and Series C preferred stock. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;As of September 30, 2011, Arrowhead owned 79% of the outstanding shares of Calando and 74% on a fully diluted basis. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 18px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&lt;i&gt;Ablaris Therapeutics, Inc. &lt;/i&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 6px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Ablaris was formed and began operations in the first quarter of fiscal 2011 through the licensing of certain anti-obesity technology developed at the MD Anderson Cancer Center at the University of Texas. During the year ended September 30, 2011, Ablaris raised $2.9 million in cash, of which $1.3 million was invested by Arrowhead and $1.6 million was invested by outside investors, through the issuance of Series A Preferred stock. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;As of September 30, 2011, Arrowhead owned 64% of the outstanding shares of Ablaris and 64% on a fully diluted basis. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 18px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&lt;i&gt;Nanotope, Inc. &lt;/i&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 6px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Nanotope is developing advanced nanomaterials for the treatment of spinal cord injuries, cartilage regeneration and wound healing. In April 2008, Arrowhead acquired a 5.8% ownership interest in Nanotope. In July and September 2008, Arrowhead acquired 1,801,802 shares of Series B Preferred Stock of Nanotope for two payments of $1 million each, increasing Arrowhead's ownership interest in Nanotope to approximately 23%. Since inception, Nanotope's revenue has been negligible. Operating expenses for the twelve months ended September 30, 2011 were approximately $1,161,000. Nanotope's net loss for the twelve months ended September 30, 2011 was $709,000. Arrowhead accounts for its investment in Nanotope using the equity method of accounting. As of September 30, 2011, Nanotope had indebtedness to Arrowhead in the amount of $1,213,000, included in other receivables, which is expected to be repaid or converted to equity. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Summarized financial information for Nanotope, Inc. is as follows: &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 0px; margin-bottom: 0px; font-size: 12px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"&gt;
&lt;tr&gt;&lt;td width="70%"&gt; &lt;/td&gt;
&lt;td valign="bottom" width="8%"&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td valign="bottom" width="8%"&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;September&amp;nbsp;30, 2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;September&amp;nbsp;30, 2010&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Current assets&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;21,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;16,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Non-current assets&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;85,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;130,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Liabilities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;1,255,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;585,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Equity&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;(1,149,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;)&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;(439,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;)&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td height="16"&gt; &lt;/td&gt;
&lt;td height="16" colspan="4"&gt; &lt;/td&gt;
&lt;td height="16" colspan="4"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;For&amp;nbsp;the&amp;nbsp;year&amp;nbsp;ended&lt;br /&gt;September&amp;nbsp;30,&amp;nbsp;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;For&amp;nbsp;the&amp;nbsp;year&amp;nbsp;ended&lt;br /&gt;September&amp;nbsp;30,&amp;nbsp;2010&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Revenue&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;515,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;9,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Operating expenses&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;1,161,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;975,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Net Loss&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;(709,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;)&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;(955,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;)&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td height="16"&gt; &lt;/td&gt;
&lt;td height="16" colspan="4"&gt; &lt;/td&gt;
&lt;td height="16" colspan="4"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;For the year ended&lt;br /&gt;September&amp;nbsp;30, 2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;For the year ended&lt;br /&gt;September&amp;nbsp;30, 2010&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Cash flows used in operating activities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;(705,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;)&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;(329,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;)&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Cash flows used in investing activities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;(31,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;)&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;(7,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;)&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Cash flows provided by financing activities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;746,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;#8212;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 18px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&lt;i&gt;Leonardo Biosystems, Inc. &lt;/i&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 6px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Leonardo is developing a drug-delivery platform technology based on novel methods of designing spheroid porous silicon microparticles that selectively accumulate in tumor vasculature. In April 2008, Arrowhead acquired a 6.13% ownership interest in Leonardo. Arrowhead accounts for its investment in Leonardo using the cost method of accounting. As of September 30, 2011, Leonardo had indebtedness to Arrowhead in the amount of $396,000, included in other receivables, which is expected to be repaid or converted to equity. As of September 30, 2011, Arrowhead's ownership interest in Leonardo was 5%.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
  <us-gaap:FairValueDisclosuresTextBlock contextRef="Duration_10_1_2010_To_9_30_2011">&lt;div&gt; &lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;
&lt;/font&gt;
&lt;div&gt;

&lt;p style="margin-top: 18px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&lt;b&gt;NOTE 8. &lt;/b&gt;&lt;b&gt;&lt;i&gt;FAIR VALUE MEASUREMENTS &amp;amp; DERIVATIVE INSTRUMENTS&lt;/i&gt;&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 6px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;The Company measures its financial assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., exit price) in an orderly transaction between market participants at the measurement date. Additionally, the Company is required to provide disclosure and categorize assets and liabilities measured at fair value into one of three different levels depending on the assumptions (i.e., inputs) used in the valuation. Level 1 provides the most reliable measure of fair value while Level 3 generally requires significant management judgment. Financial assets and liabilities are classified in their entirety based on the lowest level of input significant to the fair value measurement. The fair value hierarchy is defined as follows: &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Level 1&amp;#8212;Valuations are based on unadjusted quoted prices in active markets for identical assets or liabilities. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Level 2&amp;#8212;Valuations are based on quoted prices for similar assets or liabilities in active markets, or quoted prices in markets that are not active for which significant inputs are observable, either directly or indirectly. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Level 3&amp;#8212;Valuations are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. Inputs reflect management's best estimate of what market participants would use in valuing the asset or liability at the measurement date. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; margin-bottom: 0px; font-size: 1px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="margin-top: 0px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;The following table summarizes fair value measurements at September 30, 2010 and September 30, 2011 for assets and liabilities measured at fair value on a recurring basis: &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;September 30, 2010: &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 0px; margin-bottom: 0px; font-size: 12px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"&gt;
&lt;tr style="line-height: 0pt; visibility: hidden; color: white;"&gt;&lt;td width="69%"&gt; &lt;/td&gt;
&lt;td valign="bottom" width="2%"&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td nowrap="nowrap"&gt;&lt;font class="_mt" size="1"&gt;&lt;b&gt;$2,408,522 &lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td valign="bottom" width="2%"&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td nowrap="nowrap"&gt;&lt;font class="_mt" size="1"&gt;&lt;b&gt;$2,408,522 &lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td valign="bottom" width="2%"&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td nowrap="nowrap"&gt;&lt;font class="_mt" size="1"&gt;&lt;b&gt;$2,408,522 &lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td valign="bottom" width="2%"&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td nowrap="nowrap"&gt;&lt;font class="_mt" size="1"&gt;&lt;b&gt;$2,408,522 &lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;Level I&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;Level&amp;nbsp;II&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;Level&amp;nbsp;III&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;6,847,162&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;#8212;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;#8212;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;6,847,162&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Derivative liabilities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;#8212;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;#8212;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;2,408,522&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;2,408,522&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="margin-top: 0px; margin-bottom: 0px; font-size: 12px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="margin-top: 0px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;September 30, 2011:&lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 0px; margin-bottom: 1px; font-size: 12px;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;Level I&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;Level&amp;nbsp;II&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;Level&amp;nbsp;III&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;7,507,389&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;#8212;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;#8212;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;7,507,389&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Marketable securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;634,585&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;#8212;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;#8212;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;634,585&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Derivative assets&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;#8212;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;#8212;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;161,125&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;161,125&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Derivative liabilities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;#8212;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;#8212;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;944,980&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;944,980&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;As part of the sale of Unidym in January 2011, Arrowhead received common stock in Wisepower, originally valued at $2.5 million, $100,000 of which is due to a third party. Arrowhead has the ability to sell the shares of stock in Wisepower, subject to certain limits on volume of sales over a nine-month period ending in October 2011. During the year ended September 30, 2011, Arrowhead sold approximately 60% of the original holdings; the remaining shares had a market value of $0.6 million at September 30, 2011, and were sold for $0.5 million in October 2011. The recorded value of the stock is adjusted to fair market value based on quotations from the KOSDAQ, a Korean stock exchange, and published foreign exchange rates. Marketable securities are included as part of other current assets in the Company's consolidated balance sheet. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;As part of the sale of Unidym in January 2011, Arrowhead received a bond from Wisepower in the face amount of $2.5 million. The bond is convertible to Wisepower common stock beginning on January 17, 2012 at a price of $2.00 per share. The conversion feature is subject to derivative accounting as prescribed under ASC 815. Accordingly, the fair value of the conversion feature on the date of issuance was estimated using an option pricing model and recorded on the Company's consolidated balance sheet as a derivative asset. The fair value of the conversion feature is estimated at the end of each reporting period and the change in the fair value of the conversion feature is recorded as a nonoperating gain/loss as change in value of derivatives in Company's consolidated statement of operations. A portion of the bond is owed to a third party, as such the company records a derivative asset for the entire conversion feature and records a derivative liability for the portion related to the third party. The original fair value of the derivative relating to the third party was $26,310; the fair value at September 30, 2011 was $6,854. The loss from the change in value of the derivative asset, net of the derivative liability of $437,919 is reflected in the change in value of derivatives in the Company's consolidated statement of operations. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;During the year ended September 30, 2011, the Company recorded a loss from the change in fair value of the derivative asset, net of $437,919. The assumptions used in valuing the derivative asset as of September 30, 2011 were as follows: &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 0px; margin-bottom: 0px; font-size: 12px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="68%" align="center"&gt;
&lt;tr&gt;&lt;td width="86%"&gt; &lt;/td&gt;
&lt;td valign="bottom" width="6%"&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Risk free interest rate&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;0.4&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;%&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Expected life&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;2.3&amp;nbsp;Years&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Dividend yield&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;none&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Volatility&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;72&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;%&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;The following is a reconciliation of the derivative asset for the year ended September 30, 2011: &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 0px; margin-bottom: 0px; font-size: 12px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="68%" align="center"&gt;
&lt;tr&gt;&lt;td width="86%"&gt; &lt;/td&gt;
&lt;td valign="bottom" width="7%"&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Value at October&amp;nbsp;1, 2010&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;#8212;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Receipt of instruments&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;618,500&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Decrease in value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;(457,375&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;)&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Net settlements&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;#8212;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;nbsp;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Value at September&amp;nbsp;30, 2011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;161,125&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;nbsp;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 3px double;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 3px double;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;As part of the equity financing on June 17, 2010, as described in Note 5, Arrowhead issued warrants to acquire up to 329,649 shares of Common Stock (the "Warrants") which contain anti-dilution protection. Under the certain provisions of the Warrants, if, during the term of the Warrants, the Company issues Common Stock at a price lower than the exercise price of the Warrants, the exercise price of the Warrants would be reduced to the amount equal to the issuance price of the Common Stock. Because the Warrants have this feature, the Warrants are subject to derivative accounting as prescribed under ASC 815. Accordingly, the fair value of the Warrants on the date of issuance was estimated using an option pricing model and recorded on the Company's consolidated balance sheet as a derivative liability. The fair value of the Warrants is estimated at the end of each reporting period and the change in the fair value of the Warrants is recorded as a nonoperating gain or loss in the Company's consolidated statement of operations. During the year ended September 30, 2011, the Company recorded a gain from the change in fair value of the derivative liability of $1,501,289. The assumptions used in valuing the derivative liability as of September 30, 2011 were as follows: &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 0px; margin-bottom: 0px; font-size: 12px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="68%" align="center"&gt;
&lt;tr&gt;&lt;td width="86%"&gt; &lt;/td&gt;
&lt;td valign="bottom" width="6%"&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Risk free interest rate&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;0.9&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;%&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Expected life&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;4.2&amp;nbsp;Years&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Dividend yield&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;none&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Volatility&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;100&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;%&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 18px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;The following is a reconciliation of the derivative liability related to these warrants for through September 30, 2011: &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 0px; margin-bottom: 0px; font-size: 12px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="68%" align="center"&gt;
&lt;tr&gt;&lt;td width="84%"&gt; &lt;/td&gt;
&lt;td valign="bottom" width="7%"&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Value at October&amp;nbsp;1, 2009&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;#8212;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Receipt of instruments&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;4,169,907&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Decrease in value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;(1,761,385&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;)&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Net settlements&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;#8212;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;nbsp;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Value at October&amp;nbsp;1, 2010&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;2,408,522&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Receipt of instruments&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;#8212;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Decrease in value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;(1,501,289&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;)&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Net settlements&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;#8212;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;nbsp;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Value at September&amp;nbsp;30, 2011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;907,233&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;nbsp;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 3px double;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 3px double;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;In conjunction with the financing of Ablaris during the year ended September 30, 2011, Arrowhead sold exchange rights to certain investors whereby the investors have the right to exchange their shares of Ablaris for a prescribed number of Arrowhead shares based upon a predefined ratio. The exchange rights have a seven-year term. During the first year, the exchange right allows the holder to exchange one Ablaris share for 0.6 Arrowhead shares. This ratio declines to 0.4 in the second year, 0.3 in the third year and 0.2 in the fourth year. In the fifth year and beyond the exchange ratio is 0.1. Exchange rights for 675,000 Ablaris shares were sold during the year ended September 30, 2011, and remain outstanding at September 30, 2011. The exchange rights are subject to derivative accounting as prescribed under ASC 815. Accordingly, the fair value of the exchange rights on the date of issuance was estimated using an option pricing model and recorded on the Company's consolidated balance sheet as a derivative liability. The fair value of the exchange rights is estimated at the end of each reporting period and the change in the fair value of the exchange rights is recorded as a nonoperating gain or loss in the Company's consolidated statement of operations. During the year ended September 30, 2011, the Company recorded a gain from the change in fair value of the derivative liability of $69,758. The assumptions used in valuing the derivative liability as of September 30, 2011 were as follows: &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 0px; margin-bottom: 0px; font-size: 12px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="68%" align="center"&gt;
&lt;tr&gt;&lt;td width="86%"&gt; &lt;/td&gt;
&lt;td valign="bottom" width="6%"&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Risk free interest rate&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;1.3&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;%&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Expected life&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;6.3&amp;nbsp;Years&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Dividend yield&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;none&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Volatility&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;100&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;%&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 12px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;The following is a reconciliation of the derivative liability related to these exchange rights for the year ended September 30, 2011: &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 0px; margin-bottom: 0px; font-size: 12px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="68%" align="center"&gt;
&lt;tr&gt;&lt;td width="87%"&gt; &lt;/td&gt;
&lt;td valign="bottom" width="7%"&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Value at October&amp;nbsp;1, 2010&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;#8212;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Issuance of instruments&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;100,650&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Change in value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;(69,758&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;)&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Net settlements&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;#8212;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;nbsp;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Value at September 30, 2011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;30,892&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;nbsp;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 3px double;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 3px double;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;The carrying amounts of the Company's other financial instruments, which include accounts receivable, accounts payable, and accrued expenses approximate their respective fair values due to the relatively short-term nature of these instruments.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <us-gaap:FiniteLivedPatentsGross contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">2046836</us-gaap:FiniteLivedPatentsGross>
  <us-gaap:FiniteLivedPatentsGross contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">1731211</us-gaap:FiniteLivedPatentsGross>
  <us-gaap:FurnitureAndFixturesGross contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">335784</us-gaap:FurnitureAndFixturesGross>
  <us-gaap:FurnitureAndFixturesGross contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">285266</us-gaap:FurnitureAndFixturesGross>
  <us-gaap:GainLossOnSaleOfEquityInvestments contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">723253</us-gaap:GainLossOnSaleOfEquityInvestments>
  <us-gaap:GainLossOnSaleOfEquityInvestments contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">219540</us-gaap:GainLossOnSaleOfEquityInvestments>
  <us-gaap:GainLossOnSaleOfEquityInvestments contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">163180</us-gaap:GainLossOnSaleOfEquityInvestments>
  <us-gaap:GainLossOnSaleOfInvestments contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">-821045</us-gaap:GainLossOnSaleOfInvestments>
  <us-gaap:GainLossOnSaleOfInvestments contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">261218</us-gaap:GainLossOnSaleOfInvestments>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">-127088</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">1772</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">25590815</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">2490725</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">3821550</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">-88704308</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">-4311987</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">-8785008</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">-88704308</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">-4311987</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">-8785008</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit1" decimals="2">-0.49</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit1" decimals="2">-1.18</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit1" decimals="2">-0.49</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
  <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit1" decimals="2">-1.08</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">-42837974</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">-2645051</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">5292609</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit1" decimals="2">-0.41</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit1" decimals="2">0.74</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare xsi:nil="true" contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit1" />
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit1" decimals="2">-0.41</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit1" decimals="2">0.68</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
  <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">-723253</us-gaap:IncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">-219540</us-gaap:IncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">-163180</us-gaap:IncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeTaxDisclosureTextBlock contextRef="Duration_10_1_2010_To_9_30_2011">&lt;div&gt; &lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;
&lt;/font&gt;
&lt;div&gt;

&lt;p style="margin-top: 18px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&lt;b&gt;NOTE 9. &lt;/b&gt;&lt;b&gt;&lt;i&gt;INCOME TAXES &lt;/i&gt;&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 6px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;The Company utilizes the guidance issued by the FASB for accounting for income taxes which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; margin-bottom: 0px; font-size: 1px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="margin-top: 0px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each year-end based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The provision for income taxes represents the tax payable for the period and the change during the period in deferred tax assets and liabilities. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;For the years ended September 30, 2011 and 2010, the Company had consolidated net book losses of $3.5 million and $7.0 million, respectively. The losses result in a deferred income tax benefit which is offset by a deferred tax provision for the valuation allowance for a net deferred provision of zero. Since the Company is a development stage company, management has provided a 100% valuation allowance against its deferred tax assets until such time as management believes that its projections of future profits as well as expected future tax rates make the realization of these deferred tax assets more-likely-than-not. Significant judgment is required in the evaluation of deferred tax benefits and differences in future results from our estimates could result in material differences in the realization of these assets. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;As of September 30, 2011, the Company has available gross federal net operating loss (NOL) carry forwards of $65.3 million and gross state NOL carry forwards of $52.1 million which expire at various dates through 2029. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;As of September 30, 2011, the deferred tax assets were $25.2 million. The Company has recorded a full valuation allowance of $25.2 million related to federal and state net operating loss carry forwards. The Company has performed an assessment of positive and negative evidence regarding the realization of the net deferred tax asset in accordance with ASC 740-10, "Accounting for Income Taxes." This assessment included the evaluation of scheduled reversals of deferred tax liabilities, the availability of carry forwards and estimates of projected future taxable income. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;The Company has adopted guidance issued by the FASB that clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements and prescribes a recognition threshold of more likely than not and a measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. In making this assessment, a company must determine whether it is more likely than not that a tax position will be sustained upon examination, based solely on the technical merits of the position and must assume that the tax position will be examined by taxing authorities. Our policy is to include interest and penalties related to unrecognized tax benefits in income tax expense. Interest and penalties totaled $0 for the years ended September 30, 2011 and 2010, respectively, and $0 for the period from May 7, 2003 (date of inception) through September 30, 2011. The Company files income tax returns with the Internal Revenue Service ("IRS"), the state of California and certain other taxing jurisdictions. For jurisdictions in which tax filings are prepared, the Company is no longer subject to income tax examinations by state tax authorities for years through fiscal 2006, and by the IRS&lt;/font&gt;&lt;/p&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <us-gaap:IncomeTaxesPaid contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">742500</us-gaap:IncomeTaxesPaid>
  <us-gaap:IncomeTaxesPaid contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">742500</us-gaap:IncomeTaxesPaid>
  <us-gaap:IncomeTaxExpenseBenefit xsi:nil="true" contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" />
  <us-gaap:IncomeTaxExpenseBenefit xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" />
  <us-gaap:IncomeTaxExpenseBenefit xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" />
  <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">206434</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">-203253</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">157079</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">534540</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">110873</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">452843</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInDeposits contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">-36795</us-gaap:IncreaseDecreaseInDeposits>
  <us-gaap:IncreaseDecreaseInDeposits contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">60105</us-gaap:IncreaseDecreaseInDeposits>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">96360</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">114833</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">-18473</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">974365</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">7556</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">15751</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">1604963</us-gaap:IncreaseDecreaseInOtherReceivables>
  <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">872128</us-gaap:IncreaseDecreaseInOtherReceivables>
  <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">736253</us-gaap:IncreaseDecreaseInOtherReceivables>
  <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">142568</us-gaap:IncreaseDecreaseInPrepaidExpense>
  <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">-110152</us-gaap:IncreaseDecreaseInPrepaidExpense>
  <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">-99006</us-gaap:IncreaseDecreaseInPrepaidExpense>
  <us-gaap:IncreaseDecreaseInReceivables contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">62815</us-gaap:IncreaseDecreaseInReceivables>
  <us-gaap:IncreaseDecreaseInRestrictedCash contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">-50773</us-gaap:IncreaseDecreaseInRestrictedCash>
  <us-gaap:InterestIncomeExpenseNet contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">2714478</us-gaap:InterestIncomeExpenseNet>
  <us-gaap:InterestIncomeExpenseNet contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">-22783</us-gaap:InterestIncomeExpenseNet>
  <us-gaap:InterestIncomeExpenseNet contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">86530</us-gaap:InterestIncomeExpenseNet>
  <us-gaap:InterestPaid contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">230419</us-gaap:InterestPaid>
  <us-gaap:InterestPaid contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">105000</us-gaap:InterestPaid>
  <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">442882</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
  <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">193885</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
  <us-gaap:LaborAndRelatedExpense contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">19977209</us-gaap:LaborAndRelatedExpense>
  <us-gaap:LaborAndRelatedExpense contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">1146394</us-gaap:LaborAndRelatedExpense>
  <us-gaap:LaborAndRelatedExpense contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">1408366</us-gaap:LaborAndRelatedExpense>
  <us-gaap:LeaseholdImprovementsGross contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">78594</us-gaap:LeaseholdImprovementsGross>
  <us-gaap:LeasesOfLesseeDisclosureTextBlock contextRef="Duration_10_1_2010_To_9_30_2011">&lt;div&gt; &lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;
&lt;/font&gt;
&lt;div&gt;

&lt;p style="margin-top: 18px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&lt;b&gt;NOTE 6. &lt;/b&gt;&lt;b&gt;&lt;i&gt;LEASES &lt;/i&gt;&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 6px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;In April 2011, the Company's corporate headquarters lease expired, and the Company did not exercise its renewal option. The company is currently leasing temporary offices. The temporary offices are expected to be utilized for several months at a rental rate of approximately $8,000 per month. The current rental agreement is on a month-to-month basis and there were no long-term commitments at September 30, 2011. On October 21, 2011, Arrowhead acquired the RNAi operations from Roche, including its research facility in Madison, Wisconsin. Its lease expires on February 28, 2019; monthly rental expense is approximately $56,500. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Facility and equipment rent expense for the year ended September 30, 2011 and 2010 was $161,759 and $268,330, respectively. From inception to date, rent expense was $3,645,381. Rent expense related to Unidym, until its disposal in January 2011, is included as a part of income/loss from discontinued operations.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:LeasesOfLesseeDisclosureTextBlock>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">12354542</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">15888563</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesCurrent contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">4276246</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">2581949</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesNoncurrent contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">742446</us-gaap:LiabilitiesNoncurrent>
  <us-gaap:LongTermNotesPayable contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">606786</us-gaap:LongTermNotesPayable>
  <us-gaap:MarketableSecuritiesCurrent contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">634585</us-gaap:MarketableSecuritiesCurrent>
  <us-gaap:MarketableSecuritiesGainLoss contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">121045</us-gaap:MarketableSecuritiesGainLoss>
  <us-gaap:MarketableSecuritiesGainLoss contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">-261219</us-gaap:MarketableSecuritiesGainLoss>
  <us-gaap:MinorityInterest contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">-967406</us-gaap:MinorityInterest>
  <us-gaap:MinorityInterest contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">-226938</us-gaap:MinorityInterest>
  <us-gaap:MinorityInterestIncreaseFromStockIssuance contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">254275</us-gaap:MinorityInterestIncreaseFromStockIssuance>
  <us-gaap:MinorityInterestIncreaseFromStockIssuance xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:MinorityInterestIncreaseFromStockIssuance xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" />
  <us-gaap:MinorityInterestIncreaseFromStockIssuance xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:MinorityInterestIncreaseFromStockIssuance contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" decimals="0">254275</us-gaap:MinorityInterestIncreaseFromStockIssuance>
  <us-gaap:MinorityInterestIncreaseFromStockIssuance xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:NetCashProvidedByUsedInDiscontinuedOperations contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">-46889882</us-gaap:NetCashProvidedByUsedInDiscontinuedOperations>
  <us-gaap:NetCashProvidedByUsedInDiscontinuedOperations contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">-2284801</us-gaap:NetCashProvidedByUsedInDiscontinuedOperations>
  <us-gaap:NetCashProvidedByUsedInDiscontinuedOperations contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">2265284</us-gaap:NetCashProvidedByUsedInDiscontinuedOperations>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">118705347</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">12165156</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">6226321</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">-3770370</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">-175385</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">-60537706</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">-5053417</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">-7655993</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:NetIncomeLoss contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">-113707792</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">-5774048</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">-3128885</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">-17834490</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">-1182990</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">-363514</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:NonoperatingIncomeExpense contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">7422494</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NonoperatingIncomeExpense contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">1520834</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NonoperatingIncomeExpense contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">1045258</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NotesAndLoansReceivableNetNoncurrent contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">2272868</us-gaap:NotesAndLoansReceivableNetNoncurrent>
  <us-gaap:NotesPayableCurrent contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">500000</us-gaap:NotesPayableCurrent>
  <us-gaap:OperatingExpenses contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">100118761</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">5832821</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">10126405</us-gaap:OperatingExpenses>
  <us-gaap:OperatingIncomeLoss contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">-96126802</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">-5832821</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">-9830266</us-gaap:OperatingIncomeLoss>
  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock contextRef="Duration_10_1_2010_To_9_30_2011">&lt;div&gt; &lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;
&lt;/font&gt;
&lt;div&gt;

&lt;p style="margin-top: 18px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&lt;b&gt;NOTE 1. &lt;/b&gt;&lt;b&gt;&lt;i&gt;ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES &lt;/i&gt;&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 6px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&lt;i&gt;Nature of Business and Going Concern &lt;/i&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 6px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Arrowhead Research Corporation is a nanomedicine company developing innovative therapies at the interface of biology and nanoengineering to cure disease and improve human health. Arrowhead has one of the most advanced and broadest technology platforms for therapeutics based on RNA interference (RNAi), including access to five different RNAi delivery systems and the three primary small interfering RNA (siRNA) structures in commercial development for RNAi therapeutics. This broad technology platform enables optimization of siRNA therapeutic candidates for delivery based on siRNA chemistry, tissue type, disease state, and target [gene] and siRNA type and chemistry on a target-by-target basis. Arrowhead is leveraging its in house R&amp;amp;D expertise and capabilities, as well as a broad intellectual property portfolio for RNAi therapeutics, to attract development partnerships with other pharmaceutical and biotech companies committed to bringing RNAi therapeutics to market, as well as continuing the preclinical and clinical development its own clinical candidates. Arrowhead's non-RNAi development programs include a unique therapeutic candidate that shows promise for the treatment of obesity and advanced bioactive materials for the regeneration of injured tissues. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Arrowhead operates a wholly-owned subsidiary, Arrowhead Madison, which is focused on the development of RNAi therapeutics, two majority owned subsidiaries, Calando, a leader in delivering small interfering RNAs for gene silencing, and Ablaris, an anti-obesity therapeutics company, and has minority investments in Nanotope, a regenerative medicine company and Leonardo, a multistage drug delivery company. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 18px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&lt;i&gt;Liquidity &lt;/i&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 6px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Arrowhead has historically financed its operations through the sale of securities of Arrowhead and its Subsidiaries. Development activities at our Subsidiaries has required significant capital investment since the Company's inception and we expect our current portfolio companies to continue to require cash investment in fiscal 2012 and beyond to continue development. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;At September 30, 2011, the Company had $7.5 million in cash to fund operations. During the year ended September 30, 2011, the Company's cash position increased by $0.7 million, primarily due to the issuance of Common Stock on September 30, 2011. This financing generated $6.0 million of which $4.4 million was received in fiscal 2011, while the balance is to be received in fiscal 2012. This inflow was mostly offset by operational spending at Arrowhead, Calando and Ablaris during fiscal 2011. In January 2011, Arrowhead sold its ownership interest in Unidym; therefore the cash burn associated with Unidym ceased in January 2011. As a result of the sale of Unidym, the Company received $2.5 million in stock of the acquirer, Wisepower Co. Ltd. ("Wisepower") and a $2.5 million convertible bond from Wisepower, of which approximately $200,000 is owed to a third party, who was a minority investor in Unidym. As of September 30, 2011, the Company sold approximately 60% of the stock for approximately $1.5 million. The remaining shares were sold in October 2011, generating proceeds of $0.5 million. The convertible bond with a face value of $2.5 million, is convertible into Wisepower common stock beginning on January 17, 2012 at a price of $2.00 per share, and can be redeemed on January 17, 2013, and at which time would represent an additional source of liquidity for the company. In October 2011, the Company raised an additional $3.9 million through the issuance of preferred stock and Common Stock. The Company also entered into a facility whereby it has the ability to draw capital up to $15 million, and may do so depending on cash needs and market conditions. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;On October 21, 2011, Arrowhead completed the acquisition of certain RNAi assets from Hoffmann-La Roche Inc. and F Hoffmann-La Roche Ltd., including intellectual property and a research and development facility based in Madison, Wisconsin. At the time of the acquisition, the facility had 41 employees. Due to the costs associated with the facility, including personnel costs, rent, research and development expenses, and other costs, it is expected that cash expenses will increase significantly in 2012 and beyond as the Company accelerates its preclinical and clinical development efforts. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; margin-bottom: 0px; font-size: 1px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="margin-top: 0px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Based upon the Company's cash on hand, other sources of liquidity, as described above, and based upon the Company's operating plan, the Company's management anticipates that the Company will be able to satisfy the cash requirements of its operations through at least the next twelve months. The Company anticipates that further equity financings, and/or asset sales and license agreements will be necessary to continue to fund operations in the future. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 18px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&lt;i&gt;Summary of Significant Accounting Policies &lt;/i&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 6px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Principles of Consolidation&amp;#8212;The consolidated financial statements include the accounts of Arrowhead and its Subsidiaries, Calando, Ablaris, Tego, Agonn, and until its disposition in January 2011, Unidym. Prior to April 2008, Arrowhead's Subsidiaries included Insert Therapeutics, Inc. ("Insert"), which was merged with Calando in April 2008. The merged entity is majority-owned by Arrowhead and continues to operate under the name of Calando. On January 17, 2011, Arrowhead sold its interests in Unidym to Wisepower, and on December 23, 2009, Tego completed a sale of its assets to Luna Innovations, Inc. Unidym and Tego results are included in the Income (Loss) from Discontinued Operations. Income (Loss) from Discontinued Operations also includes Aonex Technologies, Inc. ("Aonex"), sold in May 2008 and Nanotechnica, Inc. ("Nanotechnica"), dissolved in June 2005. All significant intercompany accounts and transactions are eliminated in consolidation, and noncontrolling interests are accounted for in the Company's financial statements. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Basis of Presentation and Use of Estimates&amp;#8212;The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Significant estimates made in preparing these financial statements include valuing the stock of the Subsidiaries, assumptions to calculate stock-based compensation expense, allowance for doubtful accounts, deferred tax asset valuation allowance, derivative assets and liabilities, noncontrolling interest and useful lives for depreciable and amortizable assets. Actual results could differ from those estimates. Additionally, certain reclassifications have been made to prior period financial statements to conform to the current period presentation. In the opinion of management, all adjustments, including normal recurring accruals considered necessary for a fair presentation, have been included. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Cash and Cash Equivalents&amp;#8212;The Company considers all liquid debt instruments purchased with a maturity of three months or less to be cash equivalents. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Concentration of Credit Risk&amp;#8212;The Company maintains checking accounts for Arrowhead and separate accounts for each Subsidiary at any of three financial institutions. These accounts are insured by the Federal Deposit Insurance Corporation (FDIC) for up to $250,000 per account. The Company has two wealth management accounts at the same financial institutions that invest in higher yield money market accounts and in government securities. Management believes the Company is not exposed to significant credit risk due to the financial position of the depository institution in which these deposits are held. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Property and Equipment&amp;#8212;Property and equipment are recorded at cost. Depreciation of property and equipment is recorded using the straight-line method over the respective useful lives of the assets ranging from three to seven years. Leasehold improvements are amortized over the lesser of the expected useful life or the remaining lease term. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Intellectual Property&amp;#8212;At September 30, 2011, intellectual property consisted of patents and patent applications licensed or purchased in the gross amount of $3,349,563. The accumulated amortization of patents totaled $1,618,352 at September 30, 2011. Patents are amortized over three years to twenty years. The weighted average original amortization period is twelve years. The weighted average remaining amortization period is seven years. Amortization is expected to be $241,808 for fiscal years 2012, 2013, 2014, 2015 and 2016, and $522,174 thereafter. Long-lived assets, such as property, equipment and intangible assets subject to amortization are reviewed for impairment whenever events or circumstances indicate that the carrying amount of these assets may not be recoverable. In reviewing for impairment, we compare the carrying value of such assets to the estimated undiscounted future cash flows expected from the use of the assets and their eventual disposition. When the estimated undiscounted future cash flows are less than their carrying amount, an impairment loss is recognized equal to the difference between the assets' fair value and their carrying value. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Equity Investments&amp;#8212;Arrowhead has a non-controlling equity investment in Nanotope, a privately held biotechnology company, which is recorded in Other Assets. This investment is carried at cost less Arrowhead's proportionate share of Nanotope's operating loss for the period since investment. Arrowhead utilizes the equity method of accounting as it owns more than 20% of the voting equity and has the ability to exercise significant influence over this company. This investment is risky as the technologies and markets for Nanotope's products are still in the development stage, commercially viable products may never be developed, and markets for such products may never be significant. Arrowhead could lose its entire investment in Nanotope. Arrowhead monitors this investment for impairment and makes appropriate reductions in carrying value when necessary. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; margin-bottom: 0px; font-size: 1px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="margin-top: 0px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Minority Equity Investments&amp;#8212;The Company's minority equity investment in Leonardo, a privately held biotechnology company, is recorded in Other Assets. This investment is accounted for under the cost method of accounting as Arrowhead owns less than 20% of the voting equity and only has the ability to exercise nominal, not significant, influence over this company. This investment is risky as the technologies and markets for Leonardo's products are still in the development stage, commercially viable products may never be developed, and markets for such products may never be significant. Arrowhead could lose its entire investment in Leonardo. Arrowhead monitors this investment for impairment and makes appropriate reductions in carrying value when necessary. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Noncontrolling Interests in Majority-Owned Subsidiaries&amp;#8212;Operating losses applicable to majority-owned Calando, Ablaris and Unidym have periodically exceeded the noncontrolling interests in the equity capital of either Subsidiary. Such excess losses applicable to the noncontrolling interests have been and are borne by the Company as there is no obligation of the noncontrolling interests to fund any losses in excess of their original investment. There is also no obligation or commitment on the part of the Company to fund operating losses of any Subsidiary whether wholly-owned or majority-owned. The Company allocates the noncontrolling interest's share of net loss in excess of the noncontrolling interest's initial investment in accordance with FASB ASC 810-10, which was effective for the Company on October 1, 2009. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;When there is a change in the Company's proportionate share of a development-stage Subsidiary resulting from additional equity transactions in a Subsidiary, the change is accounted for as an equity transaction in consolidation. To the extent that the increase in the calculated value of the Company's interest in the equity of the Subsidiary exceeds the Company's investment in the offering, that increase in value is referred to as the Company's "increase in its proportionate share of the Subsidiary's equity" and the amount is recorded as an increase in the Company's Additional Paid-in Capital. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Revenue Recognition&amp;#8212;Revenue from product sales are recorded when persuasive evidence of an arrangement exists, title has passed and delivery has occurred, a price is fixed and determinable, and collection is reasonably assured. We may generate revenue from product sales, technology licenses, collaborative research and development arrangements, and research grants. Revenue under technology licenses and collaborative agreements typically consists of nonrefundable and/or guaranteed technology license fees, collaborative research funding and various milestone and future product royalty or profit-sharing payments. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Revenue associated with research and development funding payments, under collaborative agreements, is recognized ratably over the relevant periods specified in the agreement, generally the research and development period. Revenue from up-front license fees and milestones and product royalties are recognized as earned based on the completion of the milestones and product sales, as defined in the respective agreements. Payments received in advance of recognition as revenue are recorded as deferred revenue. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Allowance for Doubtful Accounts&amp;#8212;The Company accrues an allowance for doubtful accounts based on estimates of uncollectible revenues by analyzing historical collections, accounts receivable aging and other factors. Accounts receivable are written off when all collection attempts have failed. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Research and Development&amp;#8212;Costs and expenses that can be clearly identified as research and development are charged to expense as incurred in accordance with FASB ASC 730-10. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Earnings (Loss) per Share&amp;#8212;Basic earnings (loss) per share is computed using the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share are computed using the weighted-average number of common shares and dilutive potential common shares outstanding during the period. Dilutive potential common shares primarily consist of stock options issued to employees and consultants and warrants to purchase Common Stock of the Company. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Stock-Based Compensation&amp;#8212;The Company accounts for share-based compensation arrangements in accordance with FASB ASC 718, which requires the measurement and recognition of compensation expense for all share-based payment awards to be based on estimated fair values. We use the Black-Scholes option valuation model to estimate the fair value of our stock options at the date of grant. The Black-Scholes option valuation model requires the input of subjective assumptions to calculate the value of stock options. We use historical data among other information to estimate the expected price volatility and the expected forfeiture rate. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Income Taxes&amp;#8212;The Company accounts for income taxes under the liability method, which requires the recognition of deferred income tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred income tax assets to the amount expected to be realized. The provision for income taxes, if any, represents the tax payable for the period and the change in deferred income tax assets and liabilities during the period. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 18px; margin-bottom: 0px; font-size: 1px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="margin-top: 0px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&lt;b&gt;Recently Issued Accounting Standards &lt;/b&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 6px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;In June 2010, the FASB issued ASU No. 2010-17, &lt;i&gt;Revenue Recognition&amp;#8212;Milestone Method (Topic 605): Milestone Method of Revenue Recognition.&lt;/i&gt; This ASU codifies the consensus reached in EITF Issue No. 08-9, "Milestone Method of Revenue Recognition." The amendments to the Codification provide guidance on defining a milestone and determining when it may be appropriate to apply the milestone method of revenue recognition for research or development transactions. Consideration that is contingent on achievement of a milestone in its entirety may be recognized as revenue in the period in which the milestone is achieved only if the milestone is judged to meet certain criteria to be considered substantive. Milestones should be considered substantive in their entirety and may not be bifurcated. An arrangement may contain both substantive and nonsubstantive milestones, and each milestone should be evaluated individually to determine if it is substantive. This guidance was adopted effective October 1, 2010. The adoption of this guidance did not have a material impact on our consolidated financial statements. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;In January 2010, the FASB issued Accounting Standards Update ASU No. 2010-06, "Fair Value Measurements and Disclosures (Topic 820) &amp;#8211; Improving Disclosures about Fair Value Measurements". This guidance requires new disclosures related to recurring and nonrecurring fair value measurements. The guidance requires disclosure of transfers of assets and liabilities between Level 1 and Level 2 of the fair value measurement hierarchy, including the reasons and the timing of the transfers and information on purchases, sales, issuance, and settlements on a gross basis in the reconciliation of the assets and liabilities measured under Level 3 of the fair value measurement hierarchy. The adoption of this guidance is effective for interim and annual reporting periods beginning after December 15, 2009. We have adopted this guidance in the financial statements presented herein, which did not have a material impact on our consolidated financial position or results of operations. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;In October 2009, the FASB issued ASU 2009-13, which amends ASC Topic 605, &lt;i&gt;Revenue Recognition.&lt;/i&gt; This new accounting guidance relates to the revenue recognition of multiple element arrangements. The new guidance states that, if vendor specific objective evidence or third party evidence for deliverables in an arrangement cannot be determined, companies will be required to develop a best estimate of the selling price for separate deliverables and allocate arrangement consideration using the relative selling price method. We adopted this guidance as of January 1, 2010 on a prospective basis. The adoption of this guidance did not have a material impact on our consolidated financial statements. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;In October 2009, the FASB issued authoritative guidance on multiple-deliverable revenue arrangements, ASC 605-25. This guidance amends the existing criteria for separating consideration received in multiple-deliverable arrangements and requires that arrangement consideration be allocated at the inception of the arrangement to all deliverables based on their relative selling price. The guidance establishes a hierarchy for determining the selling price of a deliverable which is based on vendor-specific objective evidence, third-party evidence, or management estimates. Expanded disclosures related to multiple-deliverable revenue arrangements are also required. This guidance is effective for the Company beginning fiscal year 2011. We have adopted this guidance in the financial statements presented herein, which did not impact our consolidated financial position or results of operations.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
  <us-gaap:OtherAssetsNoncurrent contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">4081498</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:OtherAssetsNoncurrent contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">6001952</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:OtherIncome contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">250000</us-gaap:OtherIncome>
  <us-gaap:OtherIncome contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">250000</us-gaap:OtherIncome>
  <us-gaap:OtherLiabilitiesNoncurrent contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">135660</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:OtherReceivables contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">871819</us-gaap:OtherReceivables>
  <us-gaap:OtherReceivables contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">1608382</us-gaap:OtherReceivables>
  <us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">2000000</us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries>
  <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">250000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
  <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">303440</us-gaap:PaymentsToAcquireIntangibleAssets>
  <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">10150000</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
  <us-gaap:PaymentsToAcquireMarketableSecurities contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">18575915</us-gaap:PaymentsToAcquireMarketableSecurities>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">3565599</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">9674</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="As_Of_9_30_2010" unitRef="Unit1" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="As_Of_9_30_2011" unitRef="Unit1" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized contextRef="As_Of_9_30_2010" unitRef="Unit12" decimals="INF">5000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesAuthorized contextRef="As_Of_9_30_2011" unitRef="Unit12" decimals="INF">5000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued contextRef="As_Of_9_30_2010" unitRef="Unit12" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesIssued contextRef="As_Of_9_30_2011" unitRef="Unit12" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding contextRef="As_Of_9_30_2010" unitRef="Unit12" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockSharesOutstanding contextRef="As_Of_9_30_2011" unitRef="Unit12" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockValue xsi:nil="true" contextRef="As_Of_9_30_2010" unitRef="Unit13" />
  <us-gaap:PreferredStockValue xsi:nil="true" contextRef="As_Of_9_30_2011" unitRef="Unit13" />
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">353930</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">110818</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">359375</us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries>
  <us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">10529594</us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">95294780</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">12165156</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">4507389</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">2516467</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_SeriesDPreferredStockIssuedForSubscriptionInUnidymMember" unitRef="Unit13" />
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_SeriesDPreferredStockIssuedForSubscriptionInUnidymMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" decimals="0">-300000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_SeriesDPreferredStockIssuedForSubscriptionInUnidymMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">300000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_SeriesDPreferredStockIssuedForSubscriptionInUnidymMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_SeriesDPreferredStockIssuedForSubscriptionInUnidymMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_SeriesDPreferredStockIssuedForSubscriptionInUnidymMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">300000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" decimals="0">300000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" />
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">1618509</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">1618509</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">18888265</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
  <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">2804600</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
  <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">1534687</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">142375</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
  <us-gaap:ProfitLoss contextRef="Duration_10_1_2002_To_9_30_2003" unitRef="Unit13" decimals="0">-95238</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss xsi:nil="true" contextRef="Duration_10_1_2002_To_9_30_2003_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:ProfitLoss xsi:nil="true" contextRef="Duration_10_1_2002_To_9_30_2003_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" />
  <us-gaap:ProfitLoss xsi:nil="true" contextRef="Duration_10_1_2002_To_9_30_2003_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:ProfitLoss xsi:nil="true" contextRef="Duration_10_1_2002_To_9_30_2003_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:ProfitLoss contextRef="Duration_10_1_2002_To_9_30_2003_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" decimals="0">-95238</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">-131542282</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss contextRef="Duration_10_1_2003_To_9_30_2004" unitRef="Unit13" decimals="0">-751255</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:ProfitLoss xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" />
  <us-gaap:ProfitLoss xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:ProfitLoss contextRef="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" decimals="0">1777699</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss contextRef="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" decimals="0">-2528954</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss contextRef="Duration_10_1_2004_To_9_30_2005" unitRef="Unit13" decimals="0">-6733427</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss xsi:nil="true" contextRef="Duration_10_1_2004_To_9_30_2005_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:ProfitLoss xsi:nil="true" contextRef="Duration_10_1_2004_To_9_30_2005_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" />
  <us-gaap:ProfitLoss xsi:nil="true" contextRef="Duration_10_1_2004_To_9_30_2005_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:ProfitLoss contextRef="Duration_10_1_2004_To_9_30_2005_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" decimals="0">121491</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss contextRef="Duration_10_1_2004_To_9_30_2005_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" decimals="0">-6854918</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss contextRef="Duration_10_1_2005_To_9_30_2006" unitRef="Unit13" decimals="0">-19961961</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss xsi:nil="true" contextRef="Duration_10_1_2005_To_9_30_2006_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:ProfitLoss xsi:nil="true" contextRef="Duration_10_1_2005_To_9_30_2006_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" />
  <us-gaap:ProfitLoss xsi:nil="true" contextRef="Duration_10_1_2005_To_9_30_2006_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:ProfitLoss contextRef="Duration_10_1_2005_To_9_30_2006_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" decimals="0">-964752</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss contextRef="Duration_10_1_2005_To_9_30_2006_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" decimals="0">-18997209</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss contextRef="Duration_10_1_2006_To_9_30_2007" unitRef="Unit13" decimals="0">-30712947</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss xsi:nil="true" contextRef="Duration_10_1_2006_To_9_30_2007_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:ProfitLoss xsi:nil="true" contextRef="Duration_10_1_2006_To_9_30_2007_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" />
  <us-gaap:ProfitLoss xsi:nil="true" contextRef="Duration_10_1_2006_To_9_30_2007_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:ProfitLoss contextRef="Duration_10_1_2006_To_9_30_2007_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" decimals="0">-781829</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss contextRef="Duration_10_1_2006_To_9_30_2007_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" decimals="0">-29931118</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss contextRef="Duration_10_1_2007_To_9_30_2008" unitRef="Unit13" decimals="0">-27241639</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:ProfitLoss xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" />
  <us-gaap:ProfitLoss xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:ProfitLoss contextRef="Duration_10_1_2007_To_9_30_2008_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" decimals="0">-152609</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss contextRef="Duration_10_1_2007_To_9_30_2008_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" decimals="0">-27089030</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss contextRef="Duration_10_1_2008_To_9_30_2009" unitRef="Unit13" decimals="0">-19308392</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:ProfitLoss xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" />
  <us-gaap:ProfitLoss xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:ProfitLoss xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:ProfitLoss contextRef="Duration_10_1_2008_To_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" decimals="0">-19308392</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">-6957038</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:ProfitLoss xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" />
  <us-gaap:ProfitLoss xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:ProfitLoss contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" decimals="0">-1182990</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" decimals="0">-5774048</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">-3492399</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:ProfitLoss xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" />
  <us-gaap:ProfitLoss xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:ProfitLoss contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" decimals="0">-363514</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" decimals="0">-3128885</us-gaap:ProfitLoss>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">1317673</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">365801</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">141269</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">25437</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">900000</us-gaap:ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock>
  <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="Duration_10_1_2010_To_9_30_2011">&lt;div&gt; &lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;
&lt;/font&gt;
&lt;div&gt;

&lt;p style="margin-top: 18px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&lt;b&gt;NOTE 10. &lt;/b&gt;&lt;b&gt;&lt;i&gt;RELATED PARTY TRANSACTIONS &lt;/i&gt;&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 6px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Dr. Anzalone owns 1,395,900 shares of Nanotope, Inc. common stock or approximately 14.2% of Nanotope's outstanding voting securities. Dr. Anzalone does not hold options, warrants or any other rights to acquire securities of Nanotope. Dr. Anzalone has the right to appoint a representative to the board of directors of Nanotope. Dr. Anzalone currently serves on the Nanotope board in a seat reserved for Nanotope's CEO, and another individual holds the seat designated by Dr. Anzalone. Dr. Anzalone has served as President and Chief Executive Officer of Nanotope since its formation and continues to serve in these capacities. Dr. Anzalone has not received any compensation for his work on behalf of Nanotope since joining the Company on December 1, 2007. Dr. Anzalone has also waived his right to any unpaid compensation accrued for work done on behalf of Nanotope before he joined the Company. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Dr. Anzalone did not participate on behalf of the Company in the negotiations of the terms of the Nanotope Series B Preferred Stock issued to the Company and did not negotiate on behalf of Nanotope after becoming the Chief Executive Officer and President of the Company. Dr. Anzalone did respond to questions asked of him by the Company's Board of Directors and management regarding Nanotope's business plan, operations and the terms of the Series B Stock Purchase Agreement and ancillary agreements. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;During fiscal 2009, Calando raised $2.5 million through the sale of senior unsecured convertible promissory notes ("New Notes"), to accredited investors, plus $800,000 from Arrowhead. Dr. Anzalone, Arrowhead's President and CEO, personally participated in the offering by buying $100,000 of the New Notes. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;As part of the private placement on December 11, 2009 (see Note 6. Stockholder's Equity), Dr. Anzalone, Arrowhead's President and CEO, personally invested $100,000. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;In August 2010, the Company retained Mr. Vincent Anzalone, the brother of Arrowhead's Chief Executive Officer, as a consultant for the Company, focusing on business development and market analysis, with a monthly remuneration of $10,000 per month. Mr. Vincent Anzalone was paid $20,000 during the fiscal year ended September 30, 2010, and $120,000 during the fiscal year ended September 30, 2011.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
  <us-gaap:ResearchAndDevelopmentExpense contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">40428729</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">529601</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">3277760</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentInProcess contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">2685208</us-gaap:ResearchAndDevelopmentInProcess>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">-110742867</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">-113871752</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:Revenues contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">3991959</us-gaap:Revenues>
  <us-gaap:Revenues contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">296139</us-gaap:Revenues>
  <us-gaap:ShareBasedCompensation contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">12340064</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">1424293</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">1376921</us-gaap:ShareBasedCompensation>
  <us-gaap:SharesIssued contextRef="As_Of_9_30_2003_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">468000</us-gaap:SharesIssued>
  <us-gaap:SharesIssued contextRef="As_Of_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">1363155</us-gaap:SharesIssued>
  <us-gaap:SharesIssued contextRef="As_Of_9_30_2005_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">2798419</us-gaap:SharesIssued>
  <us-gaap:SharesIssued contextRef="As_Of_9_30_2006_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">3414359</us-gaap:SharesIssued>
  <us-gaap:SharesIssued contextRef="As_Of_9_30_2007_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">3861042</us-gaap:SharesIssued>
  <us-gaap:SharesIssued contextRef="As_Of_9_30_2008_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">4293452</us-gaap:SharesIssued>
  <us-gaap:SharesIssued contextRef="As_Of_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">5641177</us-gaap:SharesIssued>
  <us-gaap:SharesIssued contextRef="As_Of_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">7172014</us-gaap:SharesIssued>
  <us-gaap:SharesIssued contextRef="As_Of_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">8642286</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">9045702</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">12791106</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2003" unitRef="Unit13" decimals="0">1419762</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest xsi:nil="true" contextRef="As_Of_9_30_2003_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2003_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">1510320</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2003_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">4680</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest xsi:nil="true" contextRef="As_Of_9_30_2003_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2003_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" decimals="0">-95238</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2004" unitRef="Unit13" decimals="0">11227149</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest xsi:nil="true" contextRef="As_Of_9_30_2004_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">12059997</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">13645</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" decimals="0">1777699</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" decimals="0">-2624192</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2005" unitRef="Unit13" decimals="0">28026657</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest xsi:nil="true" contextRef="As_Of_9_30_2005_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2005_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">35578580</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2005_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">27997</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2005_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" decimals="0">1899190</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2005_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" decimals="0">-9479110</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2006" unitRef="Unit13" decimals="0">31605644</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest xsi:nil="true" contextRef="As_Of_9_30_2006_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2006_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">59113369</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2006_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">34156</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2006_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" decimals="0">934438</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2006_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" decimals="0">-28476319</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2007" unitRef="Unit13" decimals="0">26456577</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest xsi:nil="true" contextRef="As_Of_9_30_2007_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2007_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">84672783</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2007_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">38622</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2007_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" decimals="0">152609</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2007_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" decimals="0">-58407437</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2008" unitRef="Unit13" decimals="0">12302609</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest xsi:nil="true" contextRef="As_Of_9_30_2008_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2008_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">97756126</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2008_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">42950</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest xsi:nil="true" contextRef="As_Of_9_30_2008_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2008_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" decimals="0">-85496467</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2009" unitRef="Unit13" decimals="0">4857936</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2009_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" decimals="0">-300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">110070327</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">56428</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest xsi:nil="true" contextRef="As_Of_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2009_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" decimals="0">-104968819</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2010" unitRef="Unit13" decimals="0">8078296</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest xsi:nil="true" contextRef="As_Of_9_30_2010_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">119716834</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">71735</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" decimals="0">-967406</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" decimals="0">-110742867</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2011" unitRef="Unit13" decimals="0">12564168</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2011_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" decimals="0">-900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">127476435</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">86423</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" decimals="0">-226938</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="As_Of_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" decimals="0">-113871752</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="Duration_10_1_2010_To_9_30_2011">&lt;div&gt; &lt;div&gt;

&lt;p style="margin-top: 18px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&lt;b&gt;NOTE 5. &lt;/b&gt;&lt;b&gt;&lt;i&gt;STOCKHOLDERS' EQUITY &lt;/i&gt;&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 6px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;At September 30, 2011, the Company had a total of 150,000,000 shares of capital stock authorized for issuance, consisting of 145,000,000 shares of Common Stock, par value $0.001, and 5,000,000 shares of Preferred Stock, par value $0.001. On November 17, 2011, the Company effected a reverse stock split in the ratio of 1 for 10, all share and per share data below reflects an adjustment for the reverse stock split. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;At September 30, 2011, 8,642,286 shares of Common Stock were outstanding. At September 30, 2011, 153,200 shares and 575,896 shares were reserved for issuance upon exercise of options granted under Arrowhead's 2000 Stock Option Plan and 2004 Equity Incentive Plan, respectively. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;On December 11, 2009, the Company sold an aggregate of 508,343 units in a private placement transaction with accredited investors. Each unit consisted of one share of Arrowhead Common Stock and a warrant to purchase an additional share of Common Stock exercisable at $5.09 per share. The unit price was $6.34, based upon the closing bid price on the Company's Common Stock on December 11, 2009, which was $5.09, plus $1.25 for the purchase of the warrant. The warrants became exercisable on June 12, 2010 and remain exercisable until December 11, 2014. The market conditions required for redemption provided for in the warrants has been met and the warrants are eligible for redemption by the Company. Gross proceeds of the offering were approximately $3.2 million. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;On June 17, 2010, the Company sold an aggregate of 659,298 units at a price of $13.12 per unit in a registered offering to institutional and accredited investors. Each unit consisted of one share of Arrowhead Common Stock and a warrant to purchase 0.5 share of Common Stock exercisable at $16.50 per share. The warrants contain an antidilution provision which can result in an adjustment to the exercise price under certain circumstances, and the current exercise price is $3.70. Gross proceeds from the offering were $8.65 million before deducting placement agent commission and other offering expenses of approximately $800,000. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; margin-bottom: 0px; font-size: 1px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="margin-top: 0px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;On September 30, 2011, the Company sold 1,458,917 shares of Common Stock at a price of $3.80 per share. Cash proceeds received in fiscal 2011 were $4.6 million, $0.9 million are expected to be received in fiscal 2012, and $0.2 million related to a reduction in professional fees. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;The following table summarizes information about warrants outstanding at September 30, 2011: &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 0px; margin-bottom: 0px; font-size: 12px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"&gt;
&lt;tr&gt;&lt;td width="33%"&gt; &lt;/td&gt;
&lt;td valign="bottom" width="14%"&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td valign="bottom" width="14%"&gt; &lt;/td&gt;
&lt;td width="32%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="bottom" nowrap="nowrap" align="center"&gt;

&lt;p style="border-bottom: #000000 1px solid; width: 51pt;" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;Exercise&amp;nbsp;prices&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" valign="bottom" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;Number&amp;nbsp;of&amp;nbsp;Warrants&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="center"&gt;

&lt;p style="margin-top: 0px; margin-bottom: 0px;" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p style="border-bottom: #000000 1px solid; margin-top: 0px; width: 44pt; margin-bottom: 1px;" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="1"&gt;&lt;b&gt;Life&amp;nbsp;in&amp;nbsp;Years&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$70.60&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;94,896&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;5.6&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$20.00&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;386,399&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;1.9&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$5.00&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;1,163,033&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;3.2&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$5.10&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;461,024&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;3.2&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;$3.80&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;329,649&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;4.2&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 1px solid;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top"&gt;

&lt;p style="text-indent: -1em; margin-left: 1em;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Total warrants outstanding&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="center"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;2,435,001&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font class="_mt" size="1"&gt;&amp;nbsp;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;&lt;td valign="bottom"&gt; &lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td valign="bottom"&gt;

&lt;p style="border-top: #000000 3px double;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">168000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtZeroPointZeroOneDollarsPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">300000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">70553</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">15000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">35623</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtFifteenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">660879</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">47500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForMarketableSecuritiesAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">50000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2004_To_9_30_2005_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">1250</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtFifteenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">1381289</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">2500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">50226</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiftyNineDollarsAndTenCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">2536</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFortyEightDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">20485</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">1500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirtyFiveDollarsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">559000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">20838</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">284945</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">143122</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtApproximatelyEighteenDollarPerShareNetMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">386399</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">7055</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">10505</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">1500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">11416</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">5000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">205839</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">222222</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThreeDollarsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">919664</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">225189</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtSixDollarsAndThirtyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">508343</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirteenDollarsAndTwelveCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">659299</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">122000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">15318</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">8656</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuanceOfCommonStockForSubscriptionMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" />
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_10_1_2010_To_9_30_2011_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">1458917</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">7500</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">600</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTwoDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">7500</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Duration_10_1_2005_To_9_30_2006_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">11579</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Duration_10_1_2006_To_9_30_2007_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">18616</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Duration_10_1_2007_To_9_30_2008_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">10536</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">688</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="0">2700</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtTenDollarPerUnitMember" unitRef="Unit13" decimals="0">1680000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtZeroPointZeroOneDollarsPerUnitMember" unitRef="Unit13" decimals="0">3000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">1678320</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">1680</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtZeroPointZeroOneDollarsPerUnitMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtZeroPointZeroOneDollarsPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtZeroPointZeroOneDollarsPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">3000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtZeroPointZeroOneDollarsPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2002_To_9_30_2003_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtZeroPointZeroOneDollarsPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2003_To_9_30_2004" unitRef="Unit13" decimals="0">-150469</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember" unitRef="Unit13" decimals="0">162750</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember" unitRef="Unit13" decimals="0">534344</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtFifteenDollarPerUnitMember" unitRef="Unit13" decimals="0">9913182</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtTenDollarPerUnitMember" unitRef="Unit13" decimals="0">475000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForMarketableSecuritiesAtTenDollarPerUnitMember" unitRef="Unit13" decimals="0">500000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">-151175</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">706</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">162587</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">163</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">533988</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">356</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtFifteenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtFifteenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">9906573</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtFifteenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">6609</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtFifteenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtFifteenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">474525</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">475</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForCashAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForMarketableSecuritiesAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForMarketableSecuritiesAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">499500</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForMarketableSecuritiesAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">500</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForMarketableSecuritiesAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForMarketableSecuritiesAtTenDollarPerUnitMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2004_To_9_30_2005" unitRef="Unit13" decimals="0">50000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtFifteenDollarPerShareMember" unitRef="Unit13" decimals="0">20719335</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTenDollarPerShareMember" unitRef="Unit13" decimals="0">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember" unitRef="Unit13" decimals="0">2000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2004_To_9_30_2005_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2004_To_9_30_2005_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">49988</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2004_To_9_30_2005_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">12</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2004_To_9_30_2005_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2004_To_9_30_2005_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtFifteenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtFifteenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">20705522</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtFifteenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">13813</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtFifteenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtFifteenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">24975</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">25</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">1999498</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">502</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2004_To_9_30_2005_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiftyNineDollarsAndTenCentsPerShareMember" unitRef="Unit13" decimals="0">150000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFortyEightDollarsAndEightyCentsPerShareMember" unitRef="Unit13" decimals="0">1000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember" unitRef="Unit13" decimals="0">57600</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirtyFiveDollarsPerShareMember" unitRef="Unit13" decimals="0">19545000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember" unitRef="Unit13" decimals="0">1077333</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiftyNineDollarsAndTenCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiftyNineDollarsAndTenCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">149975</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiftyNineDollarsAndTenCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">25</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiftyNineDollarsAndTenCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiftyNineDollarsAndTenCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFortyEightDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFortyEightDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">999795</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFortyEightDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">205</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFortyEightDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFortyEightDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">57585</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">15</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirtyFiveDollarsPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirtyFiveDollarsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">19539410</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirtyFiveDollarsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">5590</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirtyFiveDollarsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirtyFiveDollarsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">1077125</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">208</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2005_To_9_30_2006_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember" unitRef="Unit13" decimals="0">15152215</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember" unitRef="Unit13" decimals="0">5400000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">15149366</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">2849</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">5398569</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">1431</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2006_To_9_30_2007_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtApproximatelyEighteenDollarPerShareNetMember" unitRef="Unit13" decimals="0">6960585</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember" unitRef="Unit13" decimals="0">200000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember" unitRef="Unit13" decimals="0">310000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember" unitRef="Unit13" decimals="0">32700</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember" unitRef="Unit13" decimals="0">250000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember" unitRef="Unit13" decimals="0">136000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtApproximatelyEighteenDollarPerShareNetMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtApproximatelyEighteenDollarPerShareNetMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">6956718</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtApproximatelyEighteenDollarPerShareNetMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">3867</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtApproximatelyEighteenDollarPerShareNetMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtApproximatelyEighteenDollarPerShareNetMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">199929</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">71</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">309895</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">105</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">32685</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">15</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">249886</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">114</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">135950</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">50</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember" unitRef="Unit13" decimals="0">1133676</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember" unitRef="Unit13" decimals="0">1158333</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThreeDollarsPerShareMember" unitRef="Unit13" decimals="0">2758993</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">1131617</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">2059</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">1156111</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">2222</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThreeDollarsPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThreeDollarsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">2749796</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThreeDollarsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">9197</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThreeDollarsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2008_To_9_30_2009_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThreeDollarsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">1066051</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtSixDollarsAndThirtyCentsPerShareMember" unitRef="Unit13" decimals="0">3222896</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirteenDollarsAndTwelveCentsPerShareMember" unitRef="Unit13" decimals="0">3698671</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToCalandoStockholdersInExchangeForCalandoSSharesMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">1063600</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">2251</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" decimals="0">200</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtSixDollarsAndThirtyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtSixDollarsAndThirtyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">3217813</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtSixDollarsAndThirtyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">5083</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtSixDollarsAndThirtyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtSixDollarsAndThirtyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirteenDollarsAndTwelveCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirteenDollarsAndTwelveCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">3692078</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirteenDollarsAndTwelveCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">6593</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirteenDollarsAndTwelveCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThirteenDollarsAndTwelveCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">-160667</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">1220</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" decimals="0">159447</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">-1435</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">153</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" decimals="0">1282</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">43279</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuanceOfCommonStockForSubscriptionMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2010_To_9_30_2011_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThreeDollarsAndEightyCentsPerShareMember" unitRef="Unit13" decimals="0">4643684</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">43192</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">87</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2010_To_9_30_2011_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuanceOfCommonStockForSubscriptionMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" decimals="0">-900000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2010_To_9_30_2011_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuanceOfCommonStockForSubscriptionMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">900000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuanceOfCommonStockForSubscriptionMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuanceOfCommonStockForSubscriptionMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuanceOfCommonStockForSubscriptionMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2010_To_9_30_2011_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">4629110</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Duration_10_1_2010_To_9_30_2011_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">14574</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_arwr_CommonStockIssuanceByTypeAxis_arwr_IssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Duration_10_1_2003_To_9_30_2004" unitRef="Unit13" decimals="0">15000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTenDollarPerShareMember" unitRef="Unit13" decimals="0">6000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTwoDollarPerShareMember" unitRef="Unit13" decimals="0">15000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">14925</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">75</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">5994</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">6</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTenDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTwoDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTwoDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">14925</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTwoDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">75</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTwoDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised xsi:nil="true" contextRef="Duration_10_1_2003_To_9_30_2004_arwr_CommonStockIssuanceByTypeAxis_arwr_ExercisedAtTwoDollarPerShareMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Duration_10_1_2005_To_9_30_2006" unitRef="Unit13" decimals="0">341537</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised xsi:nil="true" contextRef="Duration_10_1_2005_To_9_30_2006_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Duration_10_1_2005_To_9_30_2006_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">341421</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Duration_10_1_2005_To_9_30_2006_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">116</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised xsi:nil="true" contextRef="Duration_10_1_2005_To_9_30_2006_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised xsi:nil="true" contextRef="Duration_10_1_2005_To_9_30_2006_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Duration_10_1_2006_To_9_30_2007" unitRef="Unit13" decimals="0">434727</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised xsi:nil="true" contextRef="Duration_10_1_2006_To_9_30_2007_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Duration_10_1_2006_To_9_30_2007_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">434541</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Duration_10_1_2006_To_9_30_2007_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">186</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised xsi:nil="true" contextRef="Duration_10_1_2006_To_9_30_2007_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised xsi:nil="true" contextRef="Duration_10_1_2006_To_9_30_2007_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Duration_10_1_2007_To_9_30_2008" unitRef="Unit13" decimals="0">290027</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Duration_10_1_2007_To_9_30_2008_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">289921</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Duration_10_1_2007_To_9_30_2008_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">106</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised xsi:nil="true" contextRef="Duration_10_1_2007_To_9_30_2008_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">7631</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">7624</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">7</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised xsi:nil="true" contextRef="Duration_10_1_2009_To_9_30_2010_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">13884</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_arwr_SubscriptionsReceivableMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit13" decimals="0">13857</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit13" decimals="0">27</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="Unit13" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised xsi:nil="true" contextRef="Duration_10_1_2010_To_9_30_2011_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit13" />
  <us-gaap:SubsequentEventsTextBlock contextRef="Duration_10_1_2010_To_9_30_2011">&lt;div&gt; &lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;
&lt;/font&gt;
&lt;div&gt;

&lt;p style="margin-top: 18px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;&lt;b&gt;NOTE 12. &lt;/b&gt;&lt;b&gt;&lt;i&gt;SUBSEQUENT EVENTS&lt;/i&gt;&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 6px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;On October 21, 2011, the Company entered into a Stock and Asset Purchase Agreement (the "RNAi Purchase Agreement") with Hoffmann-La Roche Inc. and F Hoffmann-La Roche Ltd (collectively, "Roche"), pursuant to which the Company purchased from Roche (i) all of the outstanding common stock of Roche Madison Inc. ("Roche Madison") and (ii) the intellectual property rights currently held by Roche related to its RNAi business and identified in the RNAi Purchase Agreement (the "Transaction"). In consideration for the purchase of Roche Madison and the Roche RNAi assets, the Company issued to Roche a promissory note with a principal value of $50,000 and 901,702 shares of Common Stock (as adjusted for a subsequent reverse split). Additionally, the Company agreed that, subject to stockholder approval under the NASDAQ Marketplace Rules, the Company would issue an additional 146,562 (as adjusted for a subsequent reverse split) shares of Common Stock, plus a number of additional shares equal to 9.9% of the shares of Common Stock (or common stock equivalents) sold by the Company in capital raising transactions within one year from the closing, but only with respect to the first $3,118,615 of gross offering proceeds (the "Top-up Shares"). If the Company is prohibited from issuing the Top-up Shares due to NASDAQ Marketplace Rules, then the Company must instead pay the cash value of the Top-up Shares, based on the then-current fair value of such shares. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;Pursuant to the RNAi Purchase Agreement, Roche has a right of first negotiation on certain product candidates developed by the Company and its affiliates relating to the purchased assets. If the Company proposes to out-license, or enters into substantive negotiations to out-license, any Clinical Candidate or Existing Candidate (as such terms are defined in the RNAi Purchase Agreement), the Company must give detailed notice of the Candidate it proposes to out-license and negotiate exclusively and in good faith with Roche for a period of time regarding the applicable out-license. This right of first negotiation applies to all Existing Candidates and the first five Clinical Candidates for which the Company delivers notice to Roche and subsequently enters into an out-license. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;In addition to the consideration paid by the Company at the closing of the Transaction, the Company is obligated to make certain royalty and milestone payments to Roche upon the occurrence of certain events. For certain product candidates that are developed by the Company or its affiliates and that are covered by a valid claim by the patent rights transferred in the Transaction for which the Company and Roche do not enter into a licensing arrangement, the Company will be obligated to pay a 3% royalty on Net Sales (as defined in the RNAi Purchase Agreement), provided that the royalty rate may be reduced or offset in certain circumstances. The obligation to pay royalties on such candidates will last until the later of (i) the expiration of the last to expire patent right related to such product candidate that was transferred in the Transaction and (ii) ten years after the first commercial sale of such product candidate. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;The Company will also be obligated to make cash payments to Roche upon the achievement of various milestones, including the first regulatory approval of an Existing Candidate in certain jurisdictions and upon certain annual sales milestones for Existing Candidates that may receive regulatory approval. The potential payments range from $2,500,000 to $6,000,000 per milestone. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;On October 4, 2011, the Company completed a second closing to the private placement stock issuance of September 30, 2011. On October 4, 2011, the Company sold 138,157 shares of Common Stock at a price of $3.80 per share. Cash proceeds were $525,000. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;On October 20, 2011, the Company and Lincoln Park Capital Fund, LLC, an Illinois limited liability company ("LPC") entered into a $15 million purchase agreement (the "Purchase Agreement"), together with a registration rights agreement, whereby LPC agreed to purchase up to $15 million of Common Stock, subject to certain limitations, from time to time during the three-year term of the Purchase Agreement. Additionally, the Company agreed to file a registration statement with the U.S. Securities &amp;amp; Exchange Commission covering the resale of the shares that may be issued to LPC under the Purchase Agreement. After the SEC declares effective the registration statement related to the resale of such shares, the Company will have the right, in its sole discretion, over a 36-month period to sell up to $15 million of Common Stock (subject to certain limitations) to LPC, depending on certain conditions as set forth in the Purchase Agreement. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; margin-bottom: 0px; font-size: 1px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="margin-top: 0px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;On October 21, 2011 and October 24, 2011, the Company entered into Subscription Agreements with certain accredited investors (the "Series A Purchasers"), pursuant to which the Company agreed to issue and sell an aggregate of 1,015 shares of Series A Preferred Convertible Stock, $0.001 par value per share, at a purchase price of $1,000 per share. The aggregate purchase price to be paid by the Series A Purchasers for the shares of Series A Preferred is $1,015,000. The closing of the sale of the shares occurred on October 26, 2011. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;On October 21, 2011, the Company entered into a Subscription Agreement with a single accredited investor, pursuant to which the Company agreed to issue and sell an aggregate of 675,000 shares of Common Stock, $0.001 par value per share, at a purchase price of $3.70 per share. The aggregate purchase price to be paid by the purchaser for the shares of Common Stock was $2,497,500. The closing of the sale of the Common Shares is expected to occur in fiscal 2012. &lt;/font&gt;&lt;/p&gt;

&lt;p style="margin-top: 12px; text-indent: 32px; margin-bottom: 0px;"&gt;&lt;font style="font-family: Times New Roman;" class="_mt" size="2"&gt;As of November 17, 2011, the Company effected a 1 for 10 reverse stock split. As a result of the reverse stock split, each ten shares of the Company's Common Stock issued and outstanding immediately prior to the reverse split was combined into one share of Common Stock. Also, as a result of the Reverse Stock Split, the per share exercise price of, and the number of shares of Common Stock underlying Company stock options, warrants, Series A Preferred and any Common Stock based equity grants outstanding immediately prior to the reverse stock split was proportionally adjusted, based on the one-for-ten split ratio, in accordance with the terms of such options, warrants or other Common Stock based equity grants as the case may be. No fractional shares of Common Stock were issued in connection with the reverse split. Stockholders received a cash payment in lieu of any fractional shares. Unless otherwise noted, all share and per share amounts in these financial statements have been retrospectively adjusted to reflect the reverse stock split.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
  <us-gaap:UnrealizedGainLossOnDerivatives contextRef="Duration_5_7_2003_To_9_30_2011" unitRef="Unit13" decimals="0">2894512</us-gaap:UnrealizedGainLossOnDerivatives>
  <us-gaap:UnrealizedGainLossOnDerivatives contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit13" decimals="0">1761385</us-gaap:UnrealizedGainLossOnDerivatives>
  <us-gaap:UnrealizedGainLossOnDerivatives contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit13" decimals="0">1133127</us-gaap:UnrealizedGainLossOnDerivatives>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit12" decimals="0">6434245</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit12" decimals="0">7830407</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="Duration_10_1_2009_To_9_30_2010" unitRef="Unit12" decimals="0">6434245</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="Duration_10_1_2010_To_9_30_2011" unitRef="Unit12" decimals="0">7181121</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <!--Footnote Section-->
</xbrl>
